|
OMIM |
Link |
Information gain |
01 |
|
OFC1
|
[NCBI]
|
0.0037338
|
|
|
FSHMD1A
|
[NCBI]
|
0.00266817
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.00213077
|
|
|
small cell cancer of the lung
|
[NCBI]
|
0.00186548
|
|
|
ST3
|
[NCBI]
|
0.0012332
|
|
|
telomere length, mean leukocyte
|
[NCBI]
|
0.00111496
|
|
|
HBFQTL2
|
[NCBI]
|
0.00110529
|
|
|
IDDM4
|
[NCBI]
|
0.00106544
|
|
|
alopecia areata 1
|
[NCBI]
|
0.000979011
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal dominant
|
[NCBI]
|
0.000949618
|
|
|
phenylketonuria
|
[NCBI]
|
0.000851347
|
|
|
mental health wellness 1
|
[NCBI]
|
0.000798291
|
|
|
MEAX
|
[NCBI]
|
0.000798291
|
|
|
AMCX5
|
[NCBI]
|
0.000791349
|
|
|
RMSE2
|
[NCBI]
|
0.000791349
|
|
|
MRXS12
|
[NCBI]
|
0.000791349
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 2
|
[NCBI]
|
0.000791349
|
|
|
MTACR1
|
[NCBI]
|
0.000741878
|
|
|
stiff skin syndrome
|
[NCBI]
|
0.000651293
|
|
|
VDR
|
[NCBI]
|
0.000617857
|
|
|
CMTX2
|
[NCBI]
|
0.000529201
|
|
|
malaria, mild, susceptibility to
|
[NCBI]
|
0.000529201
|
|
|
MGC1
|
[NCBI]
|
0.000529201
|
|
|
RCM2
|
[NCBI]
|
0.000529201
|
|
|
spinal muscular atrophy, facioscapulohumeral type
|
[NCBI]
|
0.000529201
|
|
|
PRS
|
[NCBI]
|
0.000529201
|
|
|
parkinsonism, early-onset, with mental retardation
|
[NCBI]
|
0.000529201
|
|
|
EC1
|
[NCBI]
|
0.000529201
|
|
|
AIC
|
[NCBI]
|
0.000497012
|
|
|
EGF
|
[NCBI]
|
0.00047147
|
|
|
wieacker syndrome
|
[NCBI]
|
0.000432167
|
|
|
MHAC
|
[NCBI]
|
0.000432167
|
|
|
diaphyseal medullary stenosis with malignant fibrous histiocytoma
|
[NCBI]
|
0.000432167
|
|
|
CMTX3
|
[NCBI]
|
0.000432167
|
|
|
MCOPS4
|
[NCBI]
|
0.000432167
|
|
|
RA
|
[NCBI]
|
0.000427033
|
|
|
LDLR
|
[NCBI]
|
0.00039978
|
|
|
CNA1
|
[NCBI]
|
0.000370229
|
|
|
HBFQTL3
|
[NCBI]
|
0.000370229
|
|
|
stature quantitative trait locus 3
|
[NCBI]
|
0.000370229
|
|
|
HBFQTL4
|
[NCBI]
|
0.000370229
|
|
|
MYP1
|
[NCBI]
|
0.000370229
|
|
|
MDD
|
[NCBI]
|
0.000345101
|
|
|
CMM
|
[NCBI]
|
0.000332862
|
|
|
electroencephalogram, low-voltage
|
[NCBI]
|
0.00032496
|
|
|
AD14
|
[NCBI]
|
0.00032496
|
|
|
malignant hyperthermia, susceptibility to, 2
|
[NCBI]
|
0.00032496
|
|
|
MRX3
|
[NCBI]
|
0.00032496
|
|
|
HTC2
|
[NCBI]
|
0.00032496
|
|
|
AD13
|
[NCBI]
|
0.00032496
|
|
|
VEGF
|
[NCBI]
|
0.000314561
|
|
|
myeloproliferative syndrome, transient
|
[NCBI]
|
0.0003085
|
|
|
RNANC
|
[NCBI]
|
0.000289509
|
|
|
ATOD6
|
[NCBI]
|
0.000289509
|
|
|
ehlers-danlos syndrome, type viii
|
[NCBI]
|
0.000289509
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.000285146
|
|
|
NGFB
|
[NCBI]
|
0.000283943
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
0.000269705
|
|
|
AS
|
[NCBI]
|
0.000268394
|
|
|
CYP2D6
|
[NCBI]
|
0.000262127
|
|
|
SHFM2
|
[NCBI]
|
0.000260546
|
|
|
MCOPS1
|
[NCBI]
|
0.000236194
|
|
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
0.000236194
|
|
|
THAS
|
[NCBI]
|
0.000236194
|
|
|
XLP1
|
[NCBI]
|
0.00023213
|
|
|
RCC1
|
[NCBI]
|
0.000220165
|
|
|
PIL
|
[NCBI]
|
0.000217915
|
|
|
GCY
|
[NCBI]
|
0.000215289
|
|
|
SCZD6
|
[NCBI]
|
0.000215289
|
|
|
CF
|
[NCBI]
|
0.000213177
|
|
|
KLK3
|
[NCBI]
|
0.000209714
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000209517
|
|
|
SMA1
|
[NCBI]
|
0.000208491
|
|
|
APOB
|
[NCBI]
|
0.000208459
|
|
|
SLE
|
[NCBI]
|
0.000199647
|
|
|
microcephalic osteodysplastic primordial dwarfism, type i
|
[NCBI]
|
0.000197061
|
|
|
PRL
|
[NCBI]
|
0.000189012
|
|
|
PEE1
|
[NCBI]
|
0.000187965
|
|
|
TTR
|
[NCBI]
|
0.000186259
|
|
|
PCNA
|
[NCBI]
|
0.000182957
|
|
|
meningioma, familial
|
[NCBI]
|
0.000180119
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
0.000180119
|
|
|
HD
|
[NCBI]
|
0.000178294
|
|
|
PWS
|
[NCBI]
|
0.000177666
|
|
|
AD
|
[NCBI]
|
0.000175664
|
|
|
IDDM
|
[NCBI]
|
0.000173124
|
|
|
CHM
|
[NCBI]
|
0.000172172
|
|
|
REN
|
[NCBI]
|
0.000169441
|
|
|
LPG
|
[NCBI]
|
0.000163233
|
|
|
MAFD1
|
[NCBI]
|
0.000156529
|
|
|
ST8
|
[NCBI]
|
0.000153741
|
|
|
CBBM
|
[NCBI]
|
0.000153741
|
|
|
NPY
|
[NCBI]
|
0.000153074
|
|
|
MEN2A
|
[NCBI]
|
0.000152178
|
|
|
LPL
|
[NCBI]
|
0.000150694
|
|
|
ND
|
[NCBI]
|
0.000150175
|
|
|
STL1
|
[NCBI]
|
0.000147255
|
|
|
SCZD1
|
[NCBI]
|
0.00014623
|
|
|
neuroblastoma
|
[NCBI]
|
0.000145808
|
|
|
AVP
|
[NCBI]
|
0.000143291
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.000142084
|
|
|
TPMT
|
[NCBI]
|
0.000140549
|
|
|
GFAP
|
[NCBI]
|
0.000140364
|
|
|
hemophilia a
|
[NCBI]
|
0.000138562
|
|
|
epidermolysis bullosa dystrophica, pasini type
|
[NCBI]
|
0.000132978
|
|
|
DMD
|
[NCBI]
|
0.000132848
|
|
|
leber optic atrophy
|
[NCBI]
|
0.000130013
|
|
|
BWS
|
[NCBI]
|
0.000127917
|
|
|
EBS2
|
[NCBI]
|
0.000125703
|
|
|
CTLN2
|
[NCBI]
|
0.000125703
|
|
|
ACHE
|
[NCBI]
|
0.000124689
|
|
|
CEACAM5
|
[NCBI]
|
0.000123785
|
|
|
IGAD1
|
[NCBI]
|
0.000121794
|
|
|
FRDA
|
[NCBI]
|
0.000121642
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
0.000120725
|
|
|
RB1
|
[NCBI]
|
0.000120247
|
|
|
alcohol dependence
|
[NCBI]
|
0.000117777
|
|
|
TNF
|
[NCBI]
|
0.000117525
|
|
|
CPX
|
[NCBI]
|
0.000114543
|
|
|
DRD2
|
[NCBI]
|
0.000113818
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
0.000112796
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
0.000111463
|
|
|
PD
|
[NCBI]
|
0.000111393
|
|
|
EPO
|
[NCBI]
|
0.000110758
|
|
|
SCIDX1
|
[NCBI]
|
0.000108637
|
|
|
TYR
|
[NCBI]
|
0.000108455
|
|
|
thiopurine s-methyltransferase deficiency
|
[NCBI]
|
0.000108407
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
0.00010472
|
|
|
SHFM3
|
[NCBI]
|
0.00010472
|
|
|
ATHS
|
[NCBI]
|
0.00010472
|
|
|
MTCO2
|
[NCBI]
|
0.000103259
|
|
|
FTD
|
[NCBI]
|
0.000101089
|
|
|
HNPP
|
[NCBI]
|
0.00010097
|
|
|
obesity
|
[NCBI]
|
0.00010097
|
|
|
down syndrome
|
[NCBI]
|
0.00010097
|
|
|
RP3
|
[NCBI]
|
0.000100437
|
|
|
vitamin d-dependent rickets, type i
|
[NCBI]
|
9.93991e-05
|
|
|
SCZD4
|
[NCBI]
|
9.93991e-05
|
|
|
BDNF
|
[NCBI]
|
9.81837e-05
|
|
|
LEPR
|
[NCBI]
|
9.69913e-05
|
|
|
CJD
|
[NCBI]
|
9.64325e-05
|
|
|
CCK
|
[NCBI]
|
9.57698e-05
|
|
|
ED1
|
[NCBI]
|
9.40481e-05
|
|
|
MTND4
|
[NCBI]
|
9.31029e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
9.24559e-05
|
|
|
PTH
|
[NCBI]
|
9.19158e-05
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
9.17426e-05
|
|
|
diarrhea 1, secretory chloride, congenital
|
[NCBI]
|
9.17426e-05
|
|
|
MCDR1
|
[NCBI]
|
9.01659e-05
|
|
|
EGFR
|
[NCBI]
|
8.98987e-05
|
|
|
HBB
|
[NCBI]
|
8.91492e-05
|
|
|
amyloidosis vii
|
[NCBI]
|
8.8637e-05
|
|
|
FA
|
[NCBI]
|
8.8545e-05
|
|
|
WAS
|
[NCBI]
|
8.76194e-05
|
|
|
CHAT
|
[NCBI]
|
8.74502e-05
|
|
|
CMTX1
|
[NCBI]
|
8.68856e-05
|
|
|
PYGM
|
[NCBI]
|
8.65659e-05
|
|
|
ESR1
|
[NCBI]
|
8.51767e-05
|
|
|
HYPP
|
[NCBI]
|
8.29765e-05
|
|
|
adrenal hypoplasia, congenital, with absent pituitary luteinizing hormone
|
[NCBI]
|
8.189e-05
|
|
|
albright hereditary osteodystrophy 2
|
[NCBI]
|
8.189e-05
|
|
|
mental health wellness 2
|
[NCBI]
|
8.15868e-05
|
|
|
APOA1
|
[NCBI]
|
8.11512e-05
|
|
|
APOE
|
[NCBI]
|
8.04618e-05
|
|
|
MTTL1
|
[NCBI]
|
7.98578e-05
|
|
|
NHS
|
[NCBI]
|
7.92634e-05
|
|
|
EBR1
|
[NCBI]
|
7.92634e-05
|
|
|
AFP
|
[NCBI]
|
7.74828e-05
|
|
|
SPTA1
|
[NCBI]
|
7.57103e-05
|
|
|
citrullinemia, type ii, neonatal-onset
|
[NCBI]
|
7.56989e-05
|
|
|
CMT1A
|
[NCBI]
|
7.54819e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
7.51408e-05
|
|
|
CSNB1A
|
[NCBI]
|
7.40614e-05
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
7.28085e-05
|
|
|
COL2A1
|
[NCBI]
|
7.22697e-05
|
|
|
hyperglycerolemia
|
[NCBI]
|
7.16631e-05
|
|
|
HFE
|
[NCBI]
|
6.9233e-05
|
|
|
VHL
|
[NCBI]
|
6.86144e-05
|
|
|
CMT1B
|
[NCBI]
|
6.81239e-05
|
|
|
osteoarthritis
|
[NCBI]
|
6.72148e-05
|
|
|
monosomy 7 of bone marrow
|
[NCBI]
|
6.62519e-05
|
|
|
alzheimer disease, susceptibility to, mitochondrial
|
[NCBI]
|
6.62519e-05
|
|
|
PMD
|
[NCBI]
|
6.5945e-05
|
|
|
XPA
|
[NCBI]
|
6.47236e-05
|
|
|
DMD
|
[NCBI]
|
6.43226e-05
|
|
|
HSPA1A
|
[NCBI]
|
6.33347e-05
|
|
|
BCR
|
[NCBI]
|
6.31883e-05
|
|
|
F3
|
[NCBI]
|
6.31598e-05
|
|
|
Ii
|
[NCBI]
|
6.23531e-05
|
|
|
BTK
|
[NCBI]
|
5.99627e-05
|
|
|
ELN
|
[NCBI]
|
5.96394e-05
|
|
|
RBP3
|
[NCBI]
|
5.9624e-05
|
|
|
NRCLP1
|
[NCBI]
|
5.94694e-05
|
|
|
DKC
|
[NCBI]
|
5.94694e-05
|
|
|
ATP1A1
|
[NCBI]
|
5.89578e-05
|
|
|
MTC
|
[NCBI]
|
5.88612e-05
|
|
|
medulloblastoma
|
[NCBI]
|
5.88612e-05
|
|
|
COMT
|
[NCBI]
|
5.87515e-05
|
|
|
lipomatosis, multiple
|
[NCBI]
|
5.73046e-05
|
|
|
LEP
|
[NCBI]
|
5.70907e-05
|
|
|
von willebrand disease
|
[NCBI]
|
5.64392e-05
|
|
|
TH
|
[NCBI]
|
5.61532e-05
|
|
|
FCHL
|
[NCBI]
|
5.60666e-05
|
|
|
GRTH
|
[NCBI]
|
5.57045e-05
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 1
|
[NCBI]
|
5.57045e-05
|
|
|
AGL
|
[NCBI]
|
5.53867e-05
|
|
|
WD
|
[NCBI]
|
5.4455e-05
|
|
|
pachygyria with mental retardation and seizures
|
[NCBI]
|
5.4455e-05
|
|
|
PLGL
|
[NCBI]
|
5.4455e-05
|
|
|
DHS
|
[NCBI]
|
5.4455e-05
|
|
|
NEPPK
|
[NCBI]
|
5.4455e-05
|
|
|
SCDO3
|
[NCBI]
|
5.4455e-05
|
|
|
striatonigral degeneration, infantile, mitochondrial
|
[NCBI]
|
5.4455e-05
|
|
|
spondyloepimetaphyseal dysplasia, type ii
|
[NCBI]
|
5.4455e-05
|
|
|
ARSA
|
[NCBI]
|
5.41778e-05
|
|
|
MUC4
|
[NCBI]
|
5.40723e-05
|
|
|
CKB
|
[NCBI]
|
5.29257e-05
|
|
|
diabetes insipidus, nephrogenic, autosomal
|
[NCBI]
|
5.28291e-05
|
|
|
SRS
|
[NCBI]
|
5.26185e-05
|
|
|
TNFSF6
|
[NCBI]
|
5.2045e-05
|
|
|
HIGM1
|
[NCBI]
|
5.14391e-05
|
|
|
NPPA
|
[NCBI]
|
5.10755e-05
|
|
|
TSHB
|
[NCBI]
|
5.09304e-05
|
|
|
CAT
|
[NCBI]
|
5.03998e-05
|
|
|
NAT1
|
[NCBI]
|
5.01965e-05
|
|
|
BHC
|
[NCBI]
|
5.01929e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
|
[NCBI]
|
5.01929e-05
|
|
|
CRS1
|
[NCBI]
|
5.01929e-05
|
|
|
OA1
|
[NCBI]
|
5.0051e-05
|
|
|
vitamin d-dependent rickets, type ii
|
[NCBI]
|
5.00086e-05
|
|
|
MDLS
|
[NCBI]
|
5.00086e-05
|
|
|
SLC9A1
|
[NCBI]
|
4.99422e-05
|
|
|
SRD5A1
|
[NCBI]
|
4.99422e-05
|
|
|
GSTA2
|
[NCBI]
|
4.99422e-05
|
|
|
complement component 8 deficiency, type ii
|
[NCBI]
|
4.99422e-05
|
|
|
CRC
|
[NCBI]
|
4.99405e-05
|
|
|
ADRB3
|
[NCBI]
|
4.96277e-05
|
|
|
ATS
|
[NCBI]
|
4.86288e-05
|
|
|
SLC11A1
|
[NCBI]
|
4.85223e-05
|
|
|
NEB
|
[NCBI]
|
4.83995e-05
|
|
|
RS1
|
[NCBI]
|
4.77571e-05
|
|
|
SCA1
|
[NCBI]
|
4.75937e-05
|
|
|
VIL
|
[NCBI]
|
4.74111e-05
|
|
|
PKD1
|
[NCBI]
|
4.72226e-05
|
|
|
HNMT
|
[NCBI]
|
4.70365e-05
|
|
|
fucosidosis
|
[NCBI]
|
4.63362e-05
|
|
|
TRPS2
|
[NCBI]
|
4.60098e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
4.57396e-05
|
|
|
DYT3
|
[NCBI]
|
4.55119e-05
|
|
|
longevity
|
[NCBI]
|
4.55119e-05
|
|
|
thyroid hormonogenesis, genetic defect in, 2a
|
[NCBI]
|
4.55119e-05
|
|
|
hydatidiform mole
|
[NCBI]
|
4.55119e-05
|
|
|
ITIH1
|
[NCBI]
|
4.52137e-05
|
|
|
BMP6
|
[NCBI]
|
4.52137e-05
|
|
|
CDH13
|
[NCBI]
|
4.52137e-05
|
|
|
ACADM
|
[NCBI]
|
4.52132e-05
|
|
|
PI
|
[NCBI]
|
4.43373e-05
|
|
|
tuberous sclerosis 4
|
[NCBI]
|
4.43109e-05
|
|
|
spondyloepiphyseal dysplasia, kimberley type
|
[NCBI]
|
4.43109e-05
|
|
|
myotubular myopathy with abnormal genital development
|
[NCBI]
|
4.43109e-05
|
|
|
ubiquitin-activating enzyme, y-linked
|
[NCBI]
|
4.43109e-05
|
|
|
CELIAC3
|
[NCBI]
|
4.43109e-05
|
|
|
phosphoglycerate dehydrogenase deficiency
|
[NCBI]
|
4.43109e-05
|
|
|
PEOA4
|
[NCBI]
|
4.43109e-05
|
|
|
SHEP5
|
[NCBI]
|
4.43109e-05
|
|
|
glycogen storage disease 0, liver
|
[NCBI]
|
4.43109e-05
|
|
|
osteoarthritis with mild chondrodysplasia
|
[NCBI]
|
4.43109e-05
|
|
|
LHB
|
[NCBI]
|
4.40928e-05
|
|
|
APRT
|
[NCBI]
|
4.3846e-05
|
|
|
IGER
|
[NCBI]
|
4.35624e-05
|
|
|
CSF2RA
|
[NCBI]
|
4.32733e-05
|
|
|
APH
|
[NCBI]
|
4.32733e-05
|
|
|
NID
|
[NCBI]
|
4.32733e-05
|
|
|
INSR
|
[NCBI]
|
4.28568e-05
|
|
|
HSPA1B
|
[NCBI]
|
4.27752e-05
|
|
|
FUT3
|
[NCBI]
|
4.15368e-05
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
4.14644e-05
|
|
|
XPA
|
[NCBI]
|
4.12695e-05
|
|
|
HEMB
|
[NCBI]
|
4.02286e-05
|
|
|
NF1
|
[NCBI]
|
4.01902e-05
|
|
|
APOC1
|
[NCBI]
|
3.99665e-05
|
|
|
KLK1
|
[NCBI]
|
3.99665e-05
|
|
|
C1NH
|
[NCBI]
|
3.97192e-05
|
|
|
IP
|
[NCBI]
|
3.94315e-05
|
|
|
DYT1
|
[NCBI]
|
3.91165e-05
|
|
|
DRD1
|
[NCBI]
|
3.85339e-05
|
|
|
homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cble complementation type
|
[NCBI]
|
3.78421e-05
|
|
|
EBN2
|
[NCBI]
|
3.78421e-05
|
|
|
ASAT
|
[NCBI]
|
3.78421e-05
|
|
|
DI
|
[NCBI]
|
3.78421e-05
|
|
|
alpha-b crystallinopathy
|
[NCBI]
|
3.78421e-05
|
|
|
cataract, autosomal dominant, multiple types 1
|
[NCBI]
|
3.78421e-05
|
|
|
COL6A1
|
[NCBI]
|
3.74838e-05
|
|
|
ALPL
|
[NCBI]
|
3.74838e-05
|
|
|
CETP
|
[NCBI]
|
3.74838e-05
|
|
|
MBL2
|
[NCBI]
|
3.72472e-05
|
|
|
HSPG2
|
[NCBI]
|
3.72176e-05
|
|
|
INS
|
[NCBI]
|
3.70939e-05
|
|
|
MS
|
[NCBI]
|
3.70213e-05
|
|
|
long-chain 3-hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
3.62985e-05
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
3.62985e-05
|
|
|
glioma of brain, familial
|
[NCBI]
|
3.61224e-05
|
|
|
MOS
|
[NCBI]
|
3.60008e-05
|
|
|
LS
|
[NCBI]
|
3.58891e-05
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
3.54732e-05
|
|
|
COL1A2
|
[NCBI]
|
3.54072e-05
|
|
|
MBP
|
[NCBI]
|
3.51511e-05
|
|
|
PLA2G2A
|
[NCBI]
|
3.487e-05
|
|
|
PSNP1
|
[NCBI]
|
3.47719e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
3.47719e-05
|
|
|
DRD
|
[NCBI]
|
3.47719e-05
|
|
|
ITGB3
|
[NCBI]
|
3.45509e-05
|
|
|
MEN1
|
[NCBI]
|
3.44267e-05
|
|
|
GLS
|
[NCBI]
|
3.42428e-05
|
|
|
PRKAR1B
|
[NCBI]
|
3.42428e-05
|
|
|
AP1B1
|
[NCBI]
|
3.42428e-05
|
|
|
MCC
|
[NCBI]
|
3.42428e-05
|
|
|
GABRA3
|
[NCBI]
|
3.42428e-05
|
|
|
HMGN1
|
[NCBI]
|
3.42428e-05
|
|
|
CAST
|
[NCBI]
|
3.38144e-05
|
|
|
WS1
|
[NCBI]
|
3.33793e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type ii
|
[NCBI]
|
3.31189e-05
|
|
|
robinow-sorauf syndrome
|
[NCBI]
|
3.31189e-05
|
|
|
n-acetylglutamate synthase deficiency
|
[NCBI]
|
3.31189e-05
|
|
|
subglottic bar
|
[NCBI]
|
3.31189e-05
|
|
|
IDDM12
|
[NCBI]
|
3.31189e-05
|
|
|
NEM1
|
[NCBI]
|
3.31189e-05
|
|
|
epidermolysis bullosa of hands and feet
|
[NCBI]
|
3.31189e-05
|
|
|
watson syndrome
|
[NCBI]
|
3.31189e-05
|
|
|
hypophosphatemic rickets, x-linked recessive
|
[NCBI]
|
3.31189e-05
|
|
|
cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency
|
[NCBI]
|
3.31189e-05
|
|
|
beta thalassemia, dominant inclusion body type
|
[NCBI]
|
3.31189e-05
|
|
|
tropical calcific pancreatitis
|
[NCBI]
|
3.31189e-05
|
|
|
osteogenesis imperfecta, type viii
|
[NCBI]
|
3.31189e-05
|
|
|
thalassemia, beta+, silent allele
|
[NCBI]
|
3.31189e-05
|
|
|
APC
|
[NCBI]
|
3.2869e-05
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
3.25154e-05
|
|
|
FY
|
[NCBI]
|
3.19828e-05
|
|
|
citrullinemia, classic
|
[NCBI]
|
3.19607e-05
|
|
|
OCRL
|
[NCBI]
|
3.19607e-05
|
|
|
HSPA1L
|
[NCBI]
|
3.16052e-05
|
|
|
HTR7
|
[NCBI]
|
3.16052e-05
|
|
|
ALPPL2
|
[NCBI]
|
3.16052e-05
|
|
|
3-@beta-hydroxysteroid dehydrogenase/delta-isomerase, type i
|
[NCBI]
|
3.16052e-05
|
|
|
BMP3
|
[NCBI]
|
3.16052e-05
|
|
|
ANKK1
|
[NCBI]
|
3.16052e-05
|
|
|
MJD
|
[NCBI]
|
3.14522e-05
|
|
|
SFTPB
|
[NCBI]
|
3.10163e-05
|
|
|
CYP2C19
|
[NCBI]
|
3.10163e-05
|
|
|
C9
|
[NCBI]
|
3.10163e-05
|
|
|
TCRG
|
[NCBI]
|
3.09478e-05
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
3.06629e-05
|
|
|
SMA2
|
[NCBI]
|
3.06629e-05
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
3.06629e-05
|
|
|
SLC2A1
|
[NCBI]
|
3.01855e-05
|
|
|
RNASE3
|
[NCBI]
|
2.98899e-05
|
|
|
HMBS
|
[NCBI]
|
2.96348e-05
|
|
|
C4A
|
[NCBI]
|
2.94953e-05
|
|
|
CALB1
|
[NCBI]
|
2.94746e-05
|
|
|
CTRB1
|
[NCBI]
|
2.94746e-05
|
|
|
KCNA5
|
[NCBI]
|
2.94746e-05
|
|
|
CYP2B6
|
[NCBI]
|
2.94746e-05
|
|
|
pyruvate dehydrogenase e3-binding protein deficiency
|
[NCBI]
|
2.94238e-05
|
|
|
OCA1B
|
[NCBI]
|
2.94238e-05
|
|
|
alternating hemiplegia of childhood
|
[NCBI]
|
2.94238e-05
|
|
|
DFNA1
|
[NCBI]
|
2.94238e-05
|
|
|
PBC
|
[NCBI]
|
2.94238e-05
|
|
|
RP17
|
[NCBI]
|
2.94238e-05
|
|
|
USH2C
|
[NCBI]
|
2.94238e-05
|
|
|
DBH
|
[NCBI]
|
2.93975e-05
|
|
|
SYP
|
[NCBI]
|
2.93975e-05
|
|
|
RYR1
|
[NCBI]
|
2.90079e-05
|
|
|
RHD
|
[NCBI]
|
2.86484e-05
|
|
|
SHBG
|
[NCBI]
|
2.80282e-05
|
|
|
COL1A1
|
[NCBI]
|
2.79956e-05
|
|
|
IRF1
|
[NCBI]
|
2.79347e-05
|
|
|
COL3A1
|
[NCBI]
|
2.77215e-05
|
|
|
CLCN4
|
[NCBI]
|
2.76891e-05
|
|
|
GCGR
|
[NCBI]
|
2.76891e-05
|
|
|
ADRA2A
|
[NCBI]
|
2.76891e-05
|
|
|
CUL2
|
[NCBI]
|
2.76891e-05
|
|
|
GLRA2
|
[NCBI]
|
2.76891e-05
|
|
|
glycogen storage disease vi
|
[NCBI]
|
2.76891e-05
|
|
|
XDH
|
[NCBI]
|
2.73293e-05
|
|
|
RP2
|
[NCBI]
|
2.7304e-05
|
|
|
MAFD2
|
[NCBI]
|
2.72014e-05
|
|
|
AHR
|
[NCBI]
|
2.71644e-05
|
|
|
MTHFR
|
[NCBI]
|
2.71419e-05
|
|
|
TCOF
|
[NCBI]
|
2.70817e-05
|
|
|
MAFD6
|
[NCBI]
|
2.70749e-05
|
|
|
CSF2RY
|
[NCBI]
|
2.7035e-05
|
|
|
g8 protein
|
[NCBI]
|
2.7035e-05
|
|
|
VIS1
|
[NCBI]
|
2.7035e-05
|
|
|
ZFP3
|
[NCBI]
|
2.7035e-05
|
|
|
IL3RA
|
[NCBI]
|
2.7035e-05
|
|
|
ST11
|
[NCBI]
|
2.7035e-05
|
|
|
temporal arteritis
|
[NCBI]
|
2.69386e-05
|
|
|
isoniazid inactivation
|
[NCBI]
|
2.6896e-05
|
|
|
PTHLH
|
[NCBI]
|
2.67206e-05
|
|
|
MTND1
|
[NCBI]
|
2.64972e-05
|
|
|
XRN
|
[NCBI]
|
2.6408e-05
|
|
|
GBS
|
[NCBI]
|
2.6408e-05
|
|
|
aplastic anemia
|
[NCBI]
|
2.6408e-05
|
|
|
ichthyosis, bullous type
|
[NCBI]
|
2.6408e-05
|
|
|
thyrotoxic periodic paralysis
|
[NCBI]
|
2.6408e-05
|
|
|
pemphigus vulgaris, familial
|
[NCBI]
|
2.6408e-05
|
|
|
hemochromatosis, neonatal
|
[NCBI]
|
2.6408e-05
|
|
|
TGFB2
|
[NCBI]
|
2.61542e-05
|
|
|
SSTR1
|
[NCBI]
|
2.61542e-05
|
|
|
HCF2
|
[NCBI]
|
2.61542e-05
|
|
|
IL4R
|
[NCBI]
|
2.59783e-05
|
|
|
IS1
|
[NCBI]
|
2.56432e-05
|
|
|
MUT
|
[NCBI]
|
2.538e-05
|
|
|
KIT
|
[NCBI]
|
2.53522e-05
|
|
|
MYH7
|
[NCBI]
|
2.53522e-05
|
|
|
giant platelet syndrome
|
[NCBI]
|
2.51444e-05
|
|
|
PGM1
|
[NCBI]
|
2.49868e-05
|
|
|
PLP1
|
[NCBI]
|
2.49868e-05
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
2.4818e-05
|
|
|
behcet syndrome
|
[NCBI]
|
2.4818e-05
|
|
|
AGC1
|
[NCBI]
|
2.48097e-05
|
|
|
KRTHB6
|
[NCBI]
|
2.48097e-05
|
|
|
flaujeac factor deficiency
|
[NCBI]
|
2.48097e-05
|
|
|
DIO1
|
[NCBI]
|
2.48097e-05
|
|
|
CNGB3
|
[NCBI]
|
2.48097e-05
|
|
|
GCNT2
|
[NCBI]
|
2.48097e-05
|
|
|
TACSTD2
|
[NCBI]
|
2.48097e-05
|
|
|
GSTP1
|
[NCBI]
|
2.42528e-05
|
|
|
MPZ
|
[NCBI]
|
2.4116e-05
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
2.40726e-05
|
|
|
gastric cancer
|
[NCBI]
|
2.40726e-05
|
|
|
HBD
|
[NCBI]
|
2.39349e-05
|
|
|
AITD3
|
[NCBI]
|
2.38751e-05
|
|
|
NPHP2
|
[NCBI]
|
2.38751e-05
|
|
|
rheumatoid arthritis, systemic juvenile
|
[NCBI]
|
2.38751e-05
|
|
|
SANDO
|
[NCBI]
|
2.38751e-05
|
|
|
IBM3
|
[NCBI]
|
2.38751e-05
|
|
|
chondrodysplasia, grebe type
|
[NCBI]
|
2.38751e-05
|
|
|
psoriatic arthritis, susceptibility to
|
[NCBI]
|
2.38751e-05
|
|
|
cryptorchidism, unilateral or bilateral
|
[NCBI]
|
2.38751e-05
|
|
|
ACHM3
|
[NCBI]
|
2.38751e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 3
|
[NCBI]
|
2.38751e-05
|
|
|
IL1B
|
[NCBI]
|
2.37209e-05
|
|
|
complement component 6 deficiency
|
[NCBI]
|
2.37209e-05
|
|
|
DPYD
|
[NCBI]
|
2.37209e-05
|
|
|
CST3
|
[NCBI]
|
2.37209e-05
|
|
|
HTR1A
|
[NCBI]
|
2.36149e-05
|
|
|
CYP27A1
|
[NCBI]
|
2.36149e-05
|
|
|
CTSE
|
[NCBI]
|
2.36149e-05
|
|
|
PRM1
|
[NCBI]
|
2.36149e-05
|
|
|
LAMB1
|
[NCBI]
|
2.36149e-05
|
|
|
TP53
|
[NCBI]
|
2.35812e-05
|
|
|
IL1A
|
[NCBI]
|
2.32081e-05
|
|
|
MTRNR1
|
[NCBI]
|
2.32081e-05
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
2.31388e-05
|
|
|
oca2 gene
|
[NCBI]
|
2.27134e-05
|
|
|
PCOS1
|
[NCBI]
|
2.2587e-05
|
|
|
FMN
|
[NCBI]
|
2.25409e-05
|
|
|
SLC6A2
|
[NCBI]
|
2.25409e-05
|
|
|
POLB
|
[NCBI]
|
2.25409e-05
|
|
|
MYF5
|
[NCBI]
|
2.25409e-05
|
|
|
GLUL
|
[NCBI]
|
2.25409e-05
|
|
|
FUR
|
[NCBI]
|
2.25409e-05
|
|
|
IVL
|
[NCBI]
|
2.25409e-05
|
|
|
IGFBP1
|
[NCBI]
|
2.25409e-05
|
|
|
UGT1A1
|
[NCBI]
|
2.23159e-05
|
|
|
SAA1
|
[NCBI]
|
2.22357e-05
|
|
|
CMH
|
[NCBI]
|
2.18161e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
2.17739e-05
|
|
|
LIPC
|
[NCBI]
|
2.17104e-05
|
|
|
fructose-1,6-bisphosphatase deficiency
|
[NCBI]
|
2.17031e-05
|
|
|
ADHR
|
[NCBI]
|
2.17031e-05
|
|
|
hypoalphalipoproteinemia, primary
|
[NCBI]
|
2.17031e-05
|
|
|
NIDDM1
|
[NCBI]
|
2.17031e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
2.17031e-05
|
|
|
corticosteroid-binding globulin deficiency
|
[NCBI]
|
2.17031e-05
|
|
|
mitochondrial myopathy
|
[NCBI]
|
2.17031e-05
|
|
|
TFE3
|
[NCBI]
|
2.15664e-05
|
|
|
ART4
|
[NCBI]
|
2.15664e-05
|
|
|
GNAS
|
[NCBI]
|
2.15051e-05
|
|
|
hypertension, essential
|
[NCBI]
|
2.13879e-05
|
|
|
CDPX2
|
[NCBI]
|
2.13865e-05
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
2.13865e-05
|
|
|
PPARA
|
[NCBI]
|
2.11061e-05
|
|
|
ACP5
|
[NCBI]
|
2.11007e-05
|
|
|
G6PD
|
[NCBI]
|
2.09349e-05
|
|
|
AVPR2
|
[NCBI]
|
2.08945e-05
|
|
|
PMP22
|
[NCBI]
|
2.07203e-05
|
|
|
ODC1
|
[NCBI]
|
2.06755e-05
|
|
|
PIM1
|
[NCBI]
|
2.06755e-05
|
|
|
ITGA2
|
[NCBI]
|
2.06755e-05
|
|
|
SFTPA1
|
[NCBI]
|
2.06755e-05
|
|
|
MTHFD1
|
[NCBI]
|
2.06755e-05
|
|
|
CALCR
|
[NCBI]
|
2.06755e-05
|
|
|
FCGR2A
|
[NCBI]
|
2.06755e-05
|
|
|
HGD
|
[NCBI]
|
2.06755e-05
|
|
|
tyrosine transaminase deficiency
|
[NCBI]
|
2.06755e-05
|
|
|
ABCB4
|
[NCBI]
|
2.06755e-05
|
|
|
SMA3
|
[NCBI]
|
2.05635e-05
|
|
|
SHFM1
|
[NCBI]
|
2.05001e-05
|
|
|
ACADS
|
[NCBI]
|
2.04754e-05
|
|
|
APOC2
|
[NCBI]
|
2.04754e-05
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
2.04754e-05
|
|
|
PSACH
|
[NCBI]
|
2.0284e-05
|
|
|
PDE6B
|
[NCBI]
|
2.0069e-05
|
|
|
ADRB2
|
[NCBI]
|
2.0069e-05
|
|
|
MC4R
|
[NCBI]
|
2.00202e-05
|
|
|
JUP
|
[NCBI]
|
1.98557e-05
|
|
|
TBXA2R
|
[NCBI]
|
1.98557e-05
|
|
|
GGH
|
[NCBI]
|
1.98557e-05
|
|
|
CCL3
|
[NCBI]
|
1.98557e-05
|
|
|
NEFH
|
[NCBI]
|
1.98557e-05
|
|
|
LU
|
[NCBI]
|
1.98557e-05
|
|
|
SCN2A
|
[NCBI]
|
1.98557e-05
|
|
|
APOC3
|
[NCBI]
|
1.98557e-05
|
|
|
MAOA
|
[NCBI]
|
1.98183e-05
|
|
|
PKD3
|
[NCBI]
|
1.98115e-05
|
|
|
HCHWAD
|
[NCBI]
|
1.98115e-05
|
|
|
spondyloepimetaphyseal dysplasia, strudwick type
|
[NCBI]
|
1.98115e-05
|
|
|
corneal dystrophy, gelatinous drop-like
|
[NCBI]
|
1.98115e-05
|
|
|
SXI1
|
[NCBI]
|
1.98115e-05
|
|
|
BRIC1
|
[NCBI]
|
1.98115e-05
|
|
|
PBT
|
[NCBI]
|
1.98115e-05
|
|
|
CMT4C
|
[NCBI]
|
1.98115e-05
|
|
|
pulmonary edema of mountaineers
|
[NCBI]
|
1.98115e-05
|
|
|
OCA1A
|
[NCBI]
|
1.97732e-05
|
|
|
THRB
|
[NCBI]
|
1.97554e-05
|
|
|
FSHR
|
[NCBI]
|
1.97554e-05
|
|
|
alopecia, androgenetic
|
[NCBI]
|
1.97515e-05
|
|
|
CHS
|
[NCBI]
|
1.94549e-05
|
|
|
DES
|
[NCBI]
|
1.92917e-05
|
|
|
IGFBP3
|
[NCBI]
|
1.9097e-05
|
|
|
CNP
|
[NCBI]
|
1.9097e-05
|
|
|
APOA4
|
[NCBI]
|
1.9097e-05
|
|
|
CCKAR
|
[NCBI]
|
1.9097e-05
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
1.9014e-05
|
|
|
ACH
|
[NCBI]
|
1.88664e-05
|
|
|
DNAH14
|
[NCBI]
|
1.8851e-05
|
|
|
TSGA2
|
[NCBI]
|
1.8851e-05
|
|
|
ASMT
|
[NCBI]
|
1.8851e-05
|
|
|
PACE4
|
[NCBI]
|
1.8851e-05
|
|
|
KIF25
|
[NCBI]
|
1.8851e-05
|
|
|
TRP2
|
[NCBI]
|
1.8851e-05
|
|
|
PDGFRL
|
[NCBI]
|
1.8851e-05
|
|
|
ZNF1
|
[NCBI]
|
1.8851e-05
|
|
|
hypertension-related calcium-regulated gene
|
[NCBI]
|
1.8851e-05
|
|
|
TAF1C
|
[NCBI]
|
1.8851e-05
|
|
|
TAF1A
|
[NCBI]
|
1.8851e-05
|
|
|
DMWD
|
[NCBI]
|
1.8851e-05
|
|
|
ASMT
|
[NCBI]
|
1.8851e-05
|
|
|
PLA2G5
|
[NCBI]
|
1.8851e-05
|
|
|
TBC1D1
|
[NCBI]
|
1.8851e-05
|
|
|
TRL1
|
[NCBI]
|
1.8851e-05
|
|
|
CHRM4
|
[NCBI]
|
1.8851e-05
|
|
|
PGA3
|
[NCBI]
|
1.8851e-05
|
|
|
UBL4A
|
[NCBI]
|
1.8851e-05
|
|
|
ZP1
|
[NCBI]
|
1.8851e-05
|
|
|
MPZL2
|
[NCBI]
|
1.8851e-05
|
|
|
TRP1
|
[NCBI]
|
1.8851e-05
|
|
|
ABLIM1
|
[NCBI]
|
1.8851e-05
|
|
|
TAF1B
|
[NCBI]
|
1.8851e-05
|
|
|
TRT2
|
[NCBI]
|
1.8851e-05
|
|
|
small membrane protein 1
|
[NCBI]
|
1.8851e-05
|
|
|
NGFG
|
[NCBI]
|
1.8851e-05
|
|
|
ATP5I
|
[NCBI]
|
1.8851e-05
|
|
|
ZNF34
|
[NCBI]
|
1.8851e-05
|
|
|
SPP1
|
[NCBI]
|
1.88334e-05
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
1.87235e-05
|
|
|
IL2
|
[NCBI]
|
1.84868e-05
|
|
|
CYP1A2
|
[NCBI]
|
1.83915e-05
|
|
|
FCGR3A
|
[NCBI]
|
1.83915e-05
|
|
|
MTCYB
|
[NCBI]
|
1.82063e-05
|
|
|
HNPCC2
|
[NCBI]
|
1.81436e-05
|
|
|
kniest dysplasia
|
[NCBI]
|
1.81436e-05
|
|
|
myeloperoxidase deficiency
|
[NCBI]
|
1.81436e-05
|
|
|
scheie syndrome
|
[NCBI]
|
1.81436e-05
|
|
|
KEL
|
[NCBI]
|
1.77328e-05
|
|
|
C7
|
[NCBI]
|
1.77328e-05
|
|
|
GJA4
|
[NCBI]
|
1.77328e-05
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
1.75818e-05
|
|
|
apc gene
|
[NCBI]
|
1.74872e-05
|
|
|
MTATP6
|
[NCBI]
|
1.72061e-05
|
|
|
SURF1
|
[NCBI]
|
1.71155e-05
|
|
|
GLUD1
|
[NCBI]
|
1.71155e-05
|
|
|
JK
|
[NCBI]
|
1.71155e-05
|
|
|
ASS
|
[NCBI]
|
1.68949e-05
|
|
|
IFNG
|
[NCBI]
|
1.68897e-05
|
|
|
THC1
|
[NCBI]
|
1.66588e-05
|
|
|
MRXS13
|
[NCBI]
|
1.66588e-05
|
|
|
myotonia congenita, autosomal recessive
|
[NCBI]
|
1.66588e-05
|
|
|
chloramphenicol toxicity
|
[NCBI]
|
1.66588e-05
|
|
|
MCDC1
|
[NCBI]
|
1.66588e-05
|
|
|
gaucher disease, type ii
|
[NCBI]
|
1.66588e-05
|
|
|
SEDT
|
[NCBI]
|
1.66588e-05
|
|
|
MERRF
|
[NCBI]
|
1.66588e-05
|
|
|
sertoli cell-only syndrome, y-linked
|
[NCBI]
|
1.66588e-05
|
|
|
HBA2
|
[NCBI]
|
1.65456e-05
|
|
|
ACTC1
|
[NCBI]
|
1.65351e-05
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
1.65351e-05
|
|
|
IL9
|
[NCBI]
|
1.65351e-05
|
|
|
HADHA
|
[NCBI]
|
1.65351e-05
|
|
|
FUT2
|
[NCBI]
|
1.65351e-05
|
|
|
HSAN3
|
[NCBI]
|
1.62552e-05
|
|
|
DHCR7
|
[NCBI]
|
1.59877e-05
|
|
|
IGHV
|
[NCBI]
|
1.59877e-05
|
|
|
AMY1A
|
[NCBI]
|
1.59877e-05
|
|
|
phenylketonuria ii
|
[NCBI]
|
1.59877e-05
|
|
|
BLM
|
[NCBI]
|
1.59121e-05
|
|
|
TS
|
[NCBI]
|
1.58577e-05
|
|
|
DNAH6
|
[NCBI]
|
1.58015e-05
|
|
|
C20ORF41
|
[NCBI]
|
1.58015e-05
|
|
|
MLN
|
[NCBI]
|
1.58015e-05
|
|
|
PHGDH
|
[NCBI]
|
1.58015e-05
|
|
|
SAH
|
[NCBI]
|
1.58015e-05
|
|
|
ATP2B4
|
[NCBI]
|
1.58015e-05
|
|
|
SCN3A
|
[NCBI]
|
1.58015e-05
|
|
|
CYP2F1
|
[NCBI]
|
1.58015e-05
|
|
|
DNAH2
|
[NCBI]
|
1.58015e-05
|
|
|
CHST5
|
[NCBI]
|
1.58015e-05
|
|
|
CD79A
|
[NCBI]
|
1.58015e-05
|
|
|
RASGRF1
|
[NCBI]
|
1.58015e-05
|
|
|
IFI16
|
[NCBI]
|
1.58015e-05
|
|
|
CA10
|
[NCBI]
|
1.58015e-05
|
|
|
CCL3L2
|
[NCBI]
|
1.58015e-05
|
|
|
MUC3B
|
[NCBI]
|
1.58015e-05
|
|
|
ATP1B3
|
[NCBI]
|
1.58015e-05
|
|
|
SEA
|
[NCBI]
|
1.58015e-05
|
|
|
oncogene ovc
|
[NCBI]
|
1.58015e-05
|
|
|
locus control region, alpha
|
[NCBI]
|
1.58015e-05
|
|
|
CYP4B1
|
[NCBI]
|
1.58015e-05
|
|
|
PYGB
|
[NCBI]
|
1.58015e-05
|
|
|
TPX1
|
[NCBI]
|
1.58015e-05
|
|
|
PCSK4
|
[NCBI]
|
1.58015e-05
|
|
|
DMRT2
|
[NCBI]
|
1.58015e-05
|
|
|
ATP4A
|
[NCBI]
|
1.58015e-05
|
|
|
PCDH17
|
[NCBI]
|
1.58015e-05
|
|
|
SLC25A16
|
[NCBI]
|
1.58015e-05
|
|
|
KCNA6
|
[NCBI]
|
1.58015e-05
|
|
|
ABR
|
[NCBI]
|
1.58015e-05
|
|
|
AP1M2
|
[NCBI]
|
1.58015e-05
|
|
|
CLCN5
|
[NCBI]
|
1.54703e-05
|
|
|
CHRNA1
|
[NCBI]
|
1.54703e-05
|
|
|
TNXB
|
[NCBI]
|
1.54703e-05
|
|
|
CR1
|
[NCBI]
|
1.54703e-05
|
|
|
DRD3
|
[NCBI]
|
1.54703e-05
|
|
|
ITGB1
|
[NCBI]
|
1.54703e-05
|
|
|
MYH6
|
[NCBI]
|
1.54703e-05
|
|
|
F13A1
|
[NCBI]
|
1.54205e-05
|
|
|
alzheimer disease 2
|
[NCBI]
|
1.53263e-05
|
|
|
ARH
|
[NCBI]
|
1.53263e-05
|
|
|
KFSD
|
[NCBI]
|
1.53263e-05
|
|
|
MCDS
|
[NCBI]
|
1.53263e-05
|
|
|
EDM1
|
[NCBI]
|
1.53263e-05
|
|
|
WS2A
|
[NCBI]
|
1.53263e-05
|
|
|
argininosuccinic aciduria
|
[NCBI]
|
1.53263e-05
|
|
|
ALS2
|
[NCBI]
|
1.53263e-05
|
|
|
FGF7
|
[NCBI]
|
1.50439e-05
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
1.5031e-05
|
|
|
ASIP
|
[NCBI]
|
1.49799e-05
|
|
|
MYB
|
[NCBI]
|
1.49799e-05
|
|
|
PJS
|
[NCBI]
|
1.4621e-05
|
|
|
MPO
|
[NCBI]
|
1.45262e-05
|
|
|
TCOF1
|
[NCBI]
|
1.45142e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
1.4467e-05
|
|
|
PF4
|
[NCBI]
|
1.43271e-05
|
|
|
CORDX1
|
[NCBI]
|
1.41226e-05
|
|
|
MODY1
|
[NCBI]
|
1.41226e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
1.41226e-05
|
|
|
FRA16A
|
[NCBI]
|
1.41226e-05
|
|
|
ACHM2
|
[NCBI]
|
1.41226e-05
|
|
|
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
|
[NCBI]
|
1.41226e-05
|
|
|
gm1-gangliosidosis, type iii
|
[NCBI]
|
1.41226e-05
|
|
|
complement component 7 deficiency
|
[NCBI]
|
1.41226e-05
|
|
|
DCC
|
[NCBI]
|
1.41141e-05
|
|
|
COL4A1
|
[NCBI]
|
1.4071e-05
|
|
|
CYP11B1
|
[NCBI]
|
1.4071e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
1.4054e-05
|
|
|
SRF
|
[NCBI]
|
1.39198e-05
|
|
|
CRYZ
|
[NCBI]
|
1.38435e-05
|
|
|
HDLBP
|
[NCBI]
|
1.38435e-05
|
|
|
GNAZ
|
[NCBI]
|
1.38435e-05
|
|
|
SSTR4
|
[NCBI]
|
1.38435e-05
|
|
|
PLCG2
|
[NCBI]
|
1.38435e-05
|
|
|
EDG4
|
[NCBI]
|
1.38435e-05
|
|
|
PF4V1
|
[NCBI]
|
1.38435e-05
|
|
|
ACTG2
|
[NCBI]
|
1.38435e-05
|
|
|
DPH2
|
[NCBI]
|
1.38435e-05
|
|
|
PCSK5
|
[NCBI]
|
1.38435e-05
|
|
|
ATP4B
|
[NCBI]
|
1.38435e-05
|
|
|
CHGB
|
[NCBI]
|
1.38435e-05
|
|
|
TNNI1
|
[NCBI]
|
1.38435e-05
|
|
|
GNAI3
|
[NCBI]
|
1.38435e-05
|
|
|
GNG2
|
[NCBI]
|
1.38435e-05
|
|
|
INHBC
|
[NCBI]
|
1.38435e-05
|
|
|
RAD23A
|
[NCBI]
|
1.38435e-05
|
|
|
NDUFS2
|
[NCBI]
|
1.38435e-05
|
|
|
GAS2
|
[NCBI]
|
1.38435e-05
|
|
|
HSPCB
|
[NCBI]
|
1.38435e-05
|
|
|
GSTM3
|
[NCBI]
|
1.38435e-05
|
|
|
DPT
|
[NCBI]
|
1.38435e-05
|
|
|
CD5
|
[NCBI]
|
1.38435e-05
|
|
|
GYS2
|
[NCBI]
|
1.38435e-05
|
|
|
DNAH1
|
[NCBI]
|
1.38435e-05
|
|
|
F8A
|
[NCBI]
|
1.38435e-05
|
|
|
ETFB
|
[NCBI]
|
1.38435e-05
|
|
|
breast cancer-associated df3 antigen
|
[NCBI]
|
1.38435e-05
|
|
|
UBC
|
[NCBI]
|
1.38435e-05
|
|
|
RRAD
|
[NCBI]
|
1.38435e-05
|
|
|
BST1
|
[NCBI]
|
1.38435e-05
|
|
|
APOL4
|
[NCBI]
|
1.38435e-05
|
|
|
APOL2
|
[NCBI]
|
1.38435e-05
|
|
|
ATP1B2
|
[NCBI]
|
1.38435e-05
|
|
|
HTR1D
|
[NCBI]
|
1.38435e-05
|
|
|
PLCD1
|
[NCBI]
|
1.38435e-05
|
|
|
MFAP1
|
[NCBI]
|
1.38435e-05
|
|
|
FGFR4
|
[NCBI]
|
1.36485e-05
|
|
|
NKX2E
|
[NCBI]
|
1.36485e-05
|
|
|
MB
|
[NCBI]
|
1.33124e-05
|
|
|
RP
|
[NCBI]
|
1.32871e-05
|
|
|
MODY
|
[NCBI]
|
1.32858e-05
|
|
|
CD59
|
[NCBI]
|
1.32452e-05
|
|
|
MTND2
|
[NCBI]
|
1.32452e-05
|
|
|
LYZ
|
[NCBI]
|
1.32452e-05
|
|
|
KCNA1
|
[NCBI]
|
1.32452e-05
|
|
|
HTR2A
|
[NCBI]
|
1.32452e-05
|
|
|
SCN1A
|
[NCBI]
|
1.32452e-05
|
|
|
FGFR3
|
[NCBI]
|
1.32389e-05
|
|
|
KRAS
|
[NCBI]
|
1.31676e-05
|
|
|
PKD2
|
[NCBI]
|
1.31676e-05
|
|
|
esophageal cancer
|
[NCBI]
|
1.30294e-05
|
|
|
alpha-thalassemia/mental retardation syndrome, deletion-type
|
[NCBI]
|
1.30294e-05
|
|
|
myotonia congenita, autosomal dominant
|
[NCBI]
|
1.30294e-05
|
|
|
dent disease 1
|
[NCBI]
|
1.30294e-05
|
|
|
mowat-wilson syndrome
|
[NCBI]
|
1.30294e-05
|
|
|
CFTD
|
[NCBI]
|
1.30294e-05
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
1.30294e-05
|
|
|
PG
|
[NCBI]
|
1.26558e-05
|
|
|
PIGR
|
[NCBI]
|
1.26558e-05
|
|
|
FLOT2
|
[NCBI]
|
1.24038e-05
|
|
|
CDR1
|
[NCBI]
|
1.24038e-05
|
|
|
MOX2
|
[NCBI]
|
1.24038e-05
|
|
|
DYNC1I2
|
[NCBI]
|
1.24038e-05
|
|
|
CEBPD
|
[NCBI]
|
1.24038e-05
|
|
|
TBC1D25
|
[NCBI]
|
1.24038e-05
|
|
|
IL3RA
|
[NCBI]
|
1.24038e-05
|
|
|
TCP10
|
[NCBI]
|
1.24038e-05
|
|
|
TRIM21
|
[NCBI]
|
1.24038e-05
|
|
|
SSTR3
|
[NCBI]
|
1.24038e-05
|
|
|
HRC
|
[NCBI]
|
1.24038e-05
|
|
|
NDUFV2
|
[NCBI]
|
1.24038e-05
|
|
|
HSPA6
|
[NCBI]
|
1.24038e-05
|
|
|
MTTW
|
[NCBI]
|
1.24038e-05
|
|
|
STK19
|
[NCBI]
|
1.24038e-05
|
|
|
LECT1
|
[NCBI]
|
1.24038e-05
|
|
|
PDHB
|
[NCBI]
|
1.24038e-05
|
|
|
GABRA6
|
[NCBI]
|
1.24038e-05
|
|
|
TGFA
|
[NCBI]
|
1.24038e-05
|
|
|
SFRS2
|
[NCBI]
|
1.24038e-05
|
|
|
pepsinogen c
|
[NCBI]
|
1.24038e-05
|
|
|
B4GALNT2
|
[NCBI]
|
1.24038e-05
|
|
|
APOL3
|
[NCBI]
|
1.24038e-05
|
|
|
EHF
|
[NCBI]
|
1.24038e-05
|
|
|
RPS10
|
[NCBI]
|
1.24038e-05
|
|
|
GLRA3
|
[NCBI]
|
1.24038e-05
|
|
|
HLX1
|
[NCBI]
|
1.24038e-05
|
|
|
ACLY
|
[NCBI]
|
1.24038e-05
|
|
|
ITGB7
|
[NCBI]
|
1.24038e-05
|
|
|
saitohin
|
[NCBI]
|
1.24038e-05
|
|
|
PFKFB1
|
[NCBI]
|
1.24038e-05
|
|
|
HLA-E
|
[NCBI]
|
1.24038e-05
|
|
|
DNAH12
|
[NCBI]
|
1.24038e-05
|
|
|
ATP1A4
|
[NCBI]
|
1.24038e-05
|
|
|
REEP5
|
[NCBI]
|
1.24038e-05
|
|
|
MTTL2
|
[NCBI]
|
1.24038e-05
|
|
|
MX1
|
[NCBI]
|
1.24038e-05
|
|
|
CACNA1E
|
[NCBI]
|
1.24038e-05
|
|
|
DNAH5
|
[NCBI]
|
1.24038e-05
|
|
|
FBP1
|
[NCBI]
|
1.24038e-05
|
|
|
CD79B
|
[NCBI]
|
1.24038e-05
|
|
|
CNTF
|
[NCBI]
|
1.23897e-05
|
|
|
HBA1
|
[NCBI]
|
1.23108e-05
|
|
|
NF2
|
[NCBI]
|
1.23101e-05
|
|
|
LFNG
|
[NCBI]
|
1.21359e-05
|
|
|
SLC25A4
|
[NCBI]
|
1.21359e-05
|
|
|
diabetes insipidus, neurohypophyseal type
|
[NCBI]
|
1.20318e-05
|
|
|
FED
|
[NCBI]
|
1.20318e-05
|
|
|
robinow syndrome, autosomal recessive
|
[NCBI]
|
1.20318e-05
|
|
|
pyruvate carboxylase deficiency
|
[NCBI]
|
1.20318e-05
|
|
|
hurler-scheie syndrome
|
[NCBI]
|
1.20318e-05
|
|
|
DLB
|
[NCBI]
|
1.20318e-05
|
|
|
DRPLA
|
[NCBI]
|
1.18865e-05
|
|
|
MHS1
|
[NCBI]
|
1.18227e-05
|
|
|
XPC
|
[NCBI]
|
1.17959e-05
|
|
|
MFS
|
[NCBI]
|
1.17686e-05
|
|
|
fabry disease
|
[NCBI]
|
1.16604e-05
|
|
|
PGR
|
[NCBI]
|
1.15659e-05
|
|
|
NPC1
|
[NCBI]
|
1.14691e-05
|
|
|
COL4A5
|
[NCBI]
|
1.14691e-05
|
|
|
RBP4
|
[NCBI]
|
1.14691e-05
|
|
|
PAX3
|
[NCBI]
|
1.13013e-05
|
|
|
CCR5
|
[NCBI]
|
1.13013e-05
|
|
|
FGR
|
[NCBI]
|
1.12694e-05
|
|
|
ANXA8
|
[NCBI]
|
1.12694e-05
|
|
|
TNFRSF8
|
[NCBI]
|
1.12694e-05
|
|
|
SLC22A12
|
[NCBI]
|
1.12694e-05
|
|
|
NLGN4
|
[NCBI]
|
1.12694e-05
|
|
|
POU2F2
|
[NCBI]
|
1.12694e-05
|
|
|
LMO1
|
[NCBI]
|
1.12694e-05
|
|
|
ANXA4
|
[NCBI]
|
1.12694e-05
|
|
|
IGHD
|
[NCBI]
|
1.12694e-05
|
|
|
PCDH8
|
[NCBI]
|
1.12694e-05
|
|
|
switch-associated protein 70
|
[NCBI]
|
1.12694e-05
|
|
|
MYCL1
|
[NCBI]
|
1.12694e-05
|
|
|
TUBAL1
|
[NCBI]
|
1.12694e-05
|
|
|
SYT3
|
[NCBI]
|
1.12694e-05
|
|
|
SCAMP1
|
[NCBI]
|
1.12694e-05
|
|
|
PDHX
|
[NCBI]
|
1.12694e-05
|
|
|
DNAH9
|
[NCBI]
|
1.12694e-05
|
|
|
ART1
|
[NCBI]
|
1.12694e-05
|
|
|
MUC5B
|
[NCBI]
|
1.12694e-05
|
|
|
GCSH
|
[NCBI]
|
1.12694e-05
|
|
|
SLC7A1
|
[NCBI]
|
1.12694e-05
|
|
|
SLC9A3
|
[NCBI]
|
1.12694e-05
|
|
|
RAB8A
|
[NCBI]
|
1.12694e-05
|
|
|
ATP1B1
|
[NCBI]
|
1.12694e-05
|
|
|
PLA2G1B
|
[NCBI]
|
1.12694e-05
|
|
|
CMA1
|
[NCBI]
|
1.12694e-05
|
|
|
MTTF
|
[NCBI]
|
1.12694e-05
|
|
|
FCGR1A
|
[NCBI]
|
1.12694e-05
|
|
|
ABL2
|
[NCBI]
|
1.12694e-05
|
|
|
TCP1
|
[NCBI]
|
1.12694e-05
|
|
|
MIC2Y
|
[NCBI]
|
1.12694e-05
|
|
|
CSN10
|
[NCBI]
|
1.12694e-05
|
|
|
KIF11
|
[NCBI]
|
1.12694e-05
|
|
|
CTSF
|
[NCBI]
|
1.12694e-05
|
|
|
RRM1
|
[NCBI]
|
1.12694e-05
|
|
|
ATP1A3
|
[NCBI]
|
1.12694e-05
|
|
|
P2RY1
|
[NCBI]
|
1.12694e-05
|
|
|
CRMP1
|
[NCBI]
|
1.12694e-05
|
|
|
PRKAR2B
|
[NCBI]
|
1.12694e-05
|
|
|
bsnd gene
|
[NCBI]
|
1.12694e-05
|
|
|
UPK1B
|
[NCBI]
|
1.12694e-05
|
|
|
LW
|
[NCBI]
|
1.12694e-05
|
|
|
ADRA1A
|
[NCBI]
|
1.12694e-05
|
|
|
MUC5AC
|
[NCBI]
|
1.12694e-05
|
|
|
AGPAT2
|
[NCBI]
|
1.12694e-05
|
|
|
CHST6
|
[NCBI]
|
1.12694e-05
|
|
|
VBP1
|
[NCBI]
|
1.12694e-05
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
1.11548e-05
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
1.11178e-05
|
|
|
periodontitis, aggressive, 1
|
[NCBI]
|
1.11178e-05
|
|
|
diabetes-deafness syndrome, maternally transmitted
|
[NCBI]
|
1.11178e-05
|
|
|
alkaptonuria
|
[NCBI]
|
1.11178e-05
|
|
|
blood group, p system
|
[NCBI]
|
1.11178e-05
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
1.11178e-05
|
|
|
MUC1
|
[NCBI]
|
1.10691e-05
|
|
|
WT1
|
[NCBI]
|
1.09948e-05
|
|
|
KRT5
|
[NCBI]
|
1.08521e-05
|
|
|
COL10A1
|
[NCBI]
|
1.08521e-05
|
|
|
MTND6
|
[NCBI]
|
1.08521e-05
|
|
|
RECQL3
|
[NCBI]
|
1.08521e-05
|
|
|
GHRH
|
[NCBI]
|
1.06354e-05
|
|
|
IL5
|
[NCBI]
|
1.05603e-05
|
|
|
MTM1
|
[NCBI]
|
1.0458e-05
|
|
|
APP
|
[NCBI]
|
1.03794e-05
|
|
|
POU2F1
|
[NCBI]
|
1.03368e-05
|
|
|
MEIS2
|
[NCBI]
|
1.03368e-05
|
|
|
TSN
|
[NCBI]
|
1.03368e-05
|
|
|
VAMP1
|
[NCBI]
|
1.03368e-05
|
|
|
IL5RA
|
[NCBI]
|
1.03368e-05
|
|
|
SLC4A2
|
[NCBI]
|
1.03368e-05
|
|
|
RYK
|
[NCBI]
|
1.03368e-05
|
|
|
SPAG11
|
[NCBI]
|
1.03368e-05
|
|
|
CCL7
|
[NCBI]
|
1.03368e-05
|
|
|
DYNC2H1
|
[NCBI]
|
1.03368e-05
|
|
|
MUC3A
|
[NCBI]
|
1.03368e-05
|
|
|
ROBO2
|
[NCBI]
|
1.03368e-05
|
|
|
APOL1
|
[NCBI]
|
1.03368e-05
|
|
|
AMELY
|
[NCBI]
|
1.03368e-05
|
|
|
CLEC4A
|
[NCBI]
|
1.03368e-05
|
|
|
NEGF2
|
[NCBI]
|
1.03368e-05
|
|
|
AKR1C3
|
[NCBI]
|
1.03368e-05
|
|
|
HSF4
|
[NCBI]
|
1.03368e-05
|
|
|
NPY1R
|
[NCBI]
|
1.03368e-05
|
|
|
MYH2
|
[NCBI]
|
1.03368e-05
|
|
|
PNOC
|
[NCBI]
|
1.03368e-05
|
|
|
TBX22
|
[NCBI]
|
1.03368e-05
|
|
|
DLAT
|
[NCBI]
|
1.03368e-05
|
|
|
CAMK4
|
[NCBI]
|
1.03368e-05
|
|
|
SRP19
|
[NCBI]
|
1.03368e-05
|
|
|
GNAT1
|
[NCBI]
|
1.03368e-05
|
|
|
ADH4
|
[NCBI]
|
1.03368e-05
|
|
|
ATP2B1
|
[NCBI]
|
1.03368e-05
|
|
|
IL1R1
|
[NCBI]
|
1.03368e-05
|
|
|
RAD23B
|
[NCBI]
|
1.03368e-05
|
|
|
C1QG
|
[NCBI]
|
1.03368e-05
|
|
|
PDE6G
|
[NCBI]
|
1.03368e-05
|
|
|
ATP2C1
|
[NCBI]
|
1.03368e-05
|
|
|
GNB2
|
[NCBI]
|
1.03368e-05
|
|
|
TAP2
|
[NCBI]
|
1.03368e-05
|
|
|
KCNA2
|
[NCBI]
|
1.03368e-05
|
|
|
NPEPPS
|
[NCBI]
|
1.03368e-05
|
|
|
C1QB
|
[NCBI]
|
1.03368e-05
|
|
|
GSN
|
[NCBI]
|
1.02788e-05
|
|
|
FMO3
|
[NCBI]
|
1.02788e-05
|
|
|
PEPD
|
[NCBI]
|
1.02788e-05
|
|
|
RARA
|
[NCBI]
|
1.02788e-05
|
|
|
PRKDC
|
[NCBI]
|
1.02788e-05
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
1.02776e-05
|
|
|
factor xii deficiency
|
[NCBI]
|
1.02776e-05
|
|
|
glucose transport defect, blood-brain barrier
|
[NCBI]
|
1.02776e-05
|
|
|
bladder cancer
|
[NCBI]
|
1.02776e-05
|
|
|
SHEP2
|
[NCBI]
|
1.02776e-05
|
|
|
CCND1
|
[NCBI]
|
1.01304e-05
|
|
|
MAG
|
[NCBI]
|
1.01029e-05
|
|
|
HBG1
|
[NCBI]
|
1.00562e-05
|
|
|
AT
|
[NCBI]
|
9.83885e-06
|
|
|
NDP
|
[NCBI]
|
9.74453e-06
|
|
|
PRPH2
|
[NCBI]
|
9.74453e-06
|
|
|
IDUA
|
[NCBI]
|
9.56889e-06
|
|
|
KSR1
|
[NCBI]
|
9.5475e-06
|
|
|
NDUFS4
|
[NCBI]
|
9.5475e-06
|
|
|
DMRT1
|
[NCBI]
|
9.5475e-06
|
|
|
RNU2
|
[NCBI]
|
9.5475e-06
|
|
|
GNB1
|
[NCBI]
|
9.5475e-06
|
|
|
S100A7
|
[NCBI]
|
9.5475e-06
|
|
|
BMP5
|
[NCBI]
|
9.5475e-06
|
|
|
CCL4L1
|
[NCBI]
|
9.5475e-06
|
|
|
RXRG
|
[NCBI]
|
9.5475e-06
|
|
|
ROM1
|
[NCBI]
|
9.5475e-06
|
|
|
HSD17B1
|
[NCBI]
|
9.5475e-06
|
|
|
PTPRG
|
[NCBI]
|
9.5475e-06
|
|
|
S100B
|
[NCBI]
|
9.5475e-06
|
|
|
CSRP1
|
[NCBI]
|
9.5475e-06
|
|
|
LOXL1
|
[NCBI]
|
9.5475e-06
|
|
|
GIPR
|
[NCBI]
|
9.5475e-06
|
|
|
CHRNG
|
[NCBI]
|
9.5475e-06
|
|
|
PLCG1
|
[NCBI]
|
9.5475e-06
|
|
|
tl antigen
|
[NCBI]
|
9.5475e-06
|
|
|
SLC7A7
|
[NCBI]
|
9.5475e-06
|
|
|
CBLB
|
[NCBI]
|
9.5475e-06
|
|
|
TAC1
|
[NCBI]
|
9.5475e-06
|
|
|
ROBO1
|
[NCBI]
|
9.5475e-06
|
|
|
SLC25A13
|
[NCBI]
|
9.5475e-06
|
|
|
CPA1
|
[NCBI]
|
9.5475e-06
|
|
|
ME1
|
[NCBI]
|
9.5475e-06
|
|
|
GNAT2
|
[NCBI]
|
9.5475e-06
|
|
|
TNP1
|
[NCBI]
|
9.5475e-06
|
|
|
ATP10A
|
[NCBI]
|
9.5475e-06
|
|
|
PXE
|
[NCBI]
|
9.54162e-06
|
|
|
GIP
|
[NCBI]
|
9.52754e-06
|
|
|
HIDS
|
[NCBI]
|
9.50306e-06
|
|
|
GEFS+
|
[NCBI]
|
9.50306e-06
|
|
|
HNA
|
[NCBI]
|
9.50306e-06
|
|
|
AIED
|
[NCBI]
|
9.50306e-06
|
|
|
ESCS
|
[NCBI]
|
9.50306e-06
|
|
|
glycogen storage disease i
|
[NCBI]
|
9.49068e-06
|
|
|
JAK1
|
[NCBI]
|
9.49068e-06
|
|
|
LTA
|
[NCBI]
|
9.49068e-06
|
|
|
FN1
|
[NCBI]
|
9.49068e-06
|
|
|
CYP3A4
|
[NCBI]
|
9.49068e-06
|
|
|
BGN
|
[NCBI]
|
9.49068e-06
|
|
|
CHEK2
|
[NCBI]
|
9.24508e-06
|
|
|
PDYN
|
[NCBI]
|
9.00732e-06
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
9.00732e-06
|
|
|
GCKR
|
[NCBI]
|
8.86544e-06
|
|
|
SCG2
|
[NCBI]
|
8.86544e-06
|
|
|
glutathionuria
|
[NCBI]
|
8.86544e-06
|
|
|
CYP3A7
|
[NCBI]
|
8.86544e-06
|
|
|
BDKRB2
|
[NCBI]
|
8.86544e-06
|
|
|
PGAM1
|
[NCBI]
|
8.86544e-06
|
|
|
PVALB
|
[NCBI]
|
8.86544e-06
|
|
|
IGFBP2
|
[NCBI]
|
8.86544e-06
|
|
|
PITPN
|
[NCBI]
|
8.86544e-06
|
|
|
GRIK1
|
[NCBI]
|
8.86544e-06
|
|
|
SCGB3A2
|
[NCBI]
|
8.86544e-06
|
|
|
HRH1
|
[NCBI]
|
8.86544e-06
|
|
|
ADRA1B
|
[NCBI]
|
8.86544e-06
|
|
|
GNAI1
|
[NCBI]
|
8.86544e-06
|
|
|
MTRR
|
[NCBI]
|
8.86544e-06
|
|
|
KCNA4
|
[NCBI]
|
8.86544e-06
|
|
|
GRHPR
|
[NCBI]
|
8.86544e-06
|
|
|
CHRND
|
[NCBI]
|
8.86544e-06
|
|
|
HBQ1
|
[NCBI]
|
8.86544e-06
|
|
|
CCL3L1
|
[NCBI]
|
8.86544e-06
|
|
|
SIRT3
|
[NCBI]
|
8.86544e-06
|
|
|
GNAI2
|
[NCBI]
|
8.86544e-06
|
|
|
AR
|
[NCBI]
|
8.8491e-06
|
|
|
LQT1
|
[NCBI]
|
8.84392e-06
|
|
|
PMC
|
[NCBI]
|
8.78715e-06
|
|
|
HEPOD
|
[NCBI]
|
8.78715e-06
|
|
|
KTCN1
|
[NCBI]
|
8.78715e-06
|
|
|
MEN2B
|
[NCBI]
|
8.78715e-06
|
|
|
SMN2
|
[NCBI]
|
8.77699e-06
|
|
|
ATP7B
|
[NCBI]
|
8.77699e-06
|
|
|
MG
|
[NCBI]
|
8.65659e-06
|
|
|
GAA
|
[NCBI]
|
8.55375e-06
|
|
|
H19
|
[NCBI]
|
8.55375e-06
|
|
|
RASA1
|
[NCBI]
|
8.53594e-06
|
|
|
SCZD
|
[NCBI]
|
8.34548e-06
|
|
|
CTLA4
|
[NCBI]
|
8.33727e-06
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
8.33727e-06
|
|
|
HLA-DRA
|
[NCBI]
|
8.33727e-06
|
|
|
CEBPE
|
[NCBI]
|
8.2666e-06
|
|
|
GAS1
|
[NCBI]
|
8.2666e-06
|
|
|
RXRB
|
[NCBI]
|
8.2666e-06
|
|
|
IL2RB
|
[NCBI]
|
8.2666e-06
|
|
|
PCSK2
|
[NCBI]
|
8.2666e-06
|
|
|
SYN1
|
[NCBI]
|
8.2666e-06
|
|
|
CD28
|
[NCBI]
|
8.2666e-06
|
|
|
EPHX2
|
[NCBI]
|
8.2666e-06
|
|
|
TMSB4X
|
[NCBI]
|
8.2666e-06
|
|
|
PLCB3
|
[NCBI]
|
8.2666e-06
|
|
|
PHKA1
|
[NCBI]
|
8.2666e-06
|
|
|
MT2A
|
[NCBI]
|
8.2666e-06
|
|
|
SCO2
|
[NCBI]
|
8.2666e-06
|
|
|
TUB
|
[NCBI]
|
8.2666e-06
|
|
|
FCER1A
|
[NCBI]
|
8.2666e-06
|
|
|
ITGA5
|
[NCBI]
|
8.2666e-06
|
|
|
PTGER2
|
[NCBI]
|
8.2666e-06
|
|
|
PTGER3
|
[NCBI]
|
8.2666e-06
|
|
|
TTC10
|
[NCBI]
|
8.2666e-06
|
|
|
CYP2E
|
[NCBI]
|
8.2666e-06
|
|
|
TNNI2
|
[NCBI]
|
8.2666e-06
|
|
|
KRT2A
|
[NCBI]
|
8.2666e-06
|
|
|
PSMB9
|
[NCBI]
|
8.2666e-06
|
|
|
CXCL1
|
[NCBI]
|
8.2666e-06
|
|
|
NCAM1
|
[NCBI]
|
8.2666e-06
|
|
|
SYT2
|
[NCBI]
|
8.2666e-06
|
|
|
CD3E
|
[NCBI]
|
8.2666e-06
|
|
|
RTT
|
[NCBI]
|
8.24442e-06
|
|
|
HEXB
|
[NCBI]
|
8.12722e-06
|
|
|
BRAF
|
[NCBI]
|
8.12722e-06
|
|
|
SCN4A
|
[NCBI]
|
8.12722e-06
|
|
|
MNGIE
|
[NCBI]
|
8.12404e-06
|
|
|
pfeiffer syndrome
|
[NCBI]
|
8.12404e-06
|
|
|
GBA
|
[NCBI]
|
8.11414e-06
|
|
|
UCP1
|
[NCBI]
|
7.99473e-06
|
|
|
PMCH
|
[NCBI]
|
7.93264e-06
|
|
|
POLG
|
[NCBI]
|
7.92333e-06
|
|
|
SOX9
|
[NCBI]
|
7.92333e-06
|
|
|
CYP17A1
|
[NCBI]
|
7.92333e-06
|
|
|
POMC
|
[NCBI]
|
7.88551e-06
|
|
|
PON1
|
[NCBI]
|
7.79576e-06
|
|
|
SLC6A3
|
[NCBI]
|
7.78782e-06
|
|
|
CES
|
[NCBI]
|
7.76947e-06
|
|
|
TOP2A
|
[NCBI]
|
7.73423e-06
|
|
|
CSN2
|
[NCBI]
|
7.73423e-06
|
|
|
MUC2
|
[NCBI]
|
7.73423e-06
|
|
|
GYS1
|
[NCBI]
|
7.73423e-06
|
|
|
GP9
|
[NCBI]
|
7.73423e-06
|
|
|
TEF
|
[NCBI]
|
7.73423e-06
|
|
|
DEFB1
|
[NCBI]
|
7.73423e-06
|
|
|
GLI
|
[NCBI]
|
7.73423e-06
|
|
|
CCL4
|
[NCBI]
|
7.73423e-06
|
|
|
NPPB
|
[NCBI]
|
7.73423e-06
|
|
|
KRT16
|
[NCBI]
|
7.73423e-06
|
|
|
HPR
|
[NCBI]
|
7.73423e-06
|
|
|
MTNR1A
|
[NCBI]
|
7.73423e-06
|
|
|
NAGS
|
[NCBI]
|
7.73423e-06
|
|
|
LAMC1
|
[NCBI]
|
7.73423e-06
|
|
|
LMNB1
|
[NCBI]
|
7.73423e-06
|
|
|
ZFX
|
[NCBI]
|
7.73423e-06
|
|
|
NRXN1
|
[NCBI]
|
7.73423e-06
|
|
|
CSPG2
|
[NCBI]
|
7.73423e-06
|
|
|
MTTI
|
[NCBI]
|
7.73423e-06
|
|
|
C1QA
|
[NCBI]
|
7.73423e-06
|
|
|
HTR1B
|
[NCBI]
|
7.73423e-06
|
|
|
CD38
|
[NCBI]
|
7.73423e-06
|
|
|
OAS1
|
[NCBI]
|
7.73423e-06
|
|
|
GAS6
|
[NCBI]
|
7.73423e-06
|
|
|
tyrosinemia, type i
|
[NCBI]
|
7.72531e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
7.53292e-06
|
|
|
donohue syndrome
|
[NCBI]
|
7.50869e-06
|
|
|
mucolipidosis iv
|
[NCBI]
|
7.50869e-06
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
7.50869e-06
|
|
|
homocystinuria
|
[NCBI]
|
7.47193e-06
|
|
|
ABCA1
|
[NCBI]
|
7.34593e-06
|
|
|
DMPK
|
[NCBI]
|
7.34593e-06
|
|
|
ERBB2
|
[NCBI]
|
7.34593e-06
|
|
|
CYP7A1
|
[NCBI]
|
7.25619e-06
|
|
|
GAD1
|
[NCBI]
|
7.25619e-06
|
|
|
SAG
|
[NCBI]
|
7.25619e-06
|
|
|
CKM
|
[NCBI]
|
7.25619e-06
|
|
|
TGFB3
|
[NCBI]
|
7.25619e-06
|
|
|
CCNA2
|
[NCBI]
|
7.25619e-06
|
|
|
ECGF1
|
[NCBI]
|
7.25619e-06
|
|
|
AMBP
|
[NCBI]
|
7.25619e-06
|
|
|
MAP3K8
|
[NCBI]
|
7.25619e-06
|
|
|
PCBP2
|
[NCBI]
|
7.25619e-06
|
|
|
PFN1
|
[NCBI]
|
7.25619e-06
|
|
|
NNAT
|
[NCBI]
|
7.25619e-06
|
|
|
CX3CR1
|
[NCBI]
|
7.25619e-06
|
|
|
PAX9
|
[NCBI]
|
7.25619e-06
|
|
|
phosphoglycerate mutase, muscle, deficiency of
|
[NCBI]
|
7.25619e-06
|
|
|
C10ORF2
|
[NCBI]
|
7.25619e-06
|
|
|
MEIS1
|
[NCBI]
|
7.25619e-06
|
|
|
IL12RB1
|
[NCBI]
|
7.25619e-06
|
|
|
PON2
|
[NCBI]
|
7.25619e-06
|
|
|
BFSP2
|
[NCBI]
|
7.25619e-06
|
|
|
HBG2
|
[NCBI]
|
7.1641e-06
|
|
|
ALAD
|
[NCBI]
|
7.1641e-06
|
|
|
MSTN
|
[NCBI]
|
6.98723e-06
|
|
|
WAS
|
[NCBI]
|
6.98723e-06
|
|
|
CLN1
|
[NCBI]
|
6.93676e-06
|
|
|
MADD
|
[NCBI]
|
6.93676e-06
|
|
|
USH2A
|
[NCBI]
|
6.93676e-06
|
|
|
diastrophic dysplasia
|
[NCBI]
|
6.93676e-06
|
|
|
IDH1
|
[NCBI]
|
6.8234e-06
|
|
|
F13B
|
[NCBI]
|
6.8234e-06
|
|
|
SULT1A1
|
[NCBI]
|
6.8234e-06
|
|
|
STMN1
|
[NCBI]
|
6.8234e-06
|
|
|
CTNNA1
|
[NCBI]
|
6.8234e-06
|
|
|
XBP1
|
[NCBI]
|
6.8234e-06
|
|
|
SILV
|
[NCBI]
|
6.8234e-06
|
|
|
SOX3
|
[NCBI]
|
6.8234e-06
|
|
|
NP
|
[NCBI]
|
6.81512e-06
|
|
|
factor vii deficiency
|
[NCBI]
|
6.81512e-06
|
|
|
LAM
|
[NCBI]
|
6.73804e-06
|
|
|
GPI
|
[NCBI]
|
6.5753e-06
|
|
|
TFPI
|
[NCBI]
|
6.5729e-06
|
|
|
KRT20
|
[NCBI]
|
6.54434e-06
|
|
|
CASR
|
[NCBI]
|
6.52015e-06
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
6.49661e-06
|
|
|
IGHG1
|
[NCBI]
|
6.48447e-06
|
|
|
MPI
|
[NCBI]
|
6.42886e-06
|
|
|
SFTPC
|
[NCBI]
|
6.42886e-06
|
|
|
CA4
|
[NCBI]
|
6.42886e-06
|
|
|
FYN
|
[NCBI]
|
6.42886e-06
|
|
|
CRYGA
|
[NCBI]
|
6.42886e-06
|
|
|
NCF2
|
[NCBI]
|
6.42886e-06
|
|
|
MSR1
|
[NCBI]
|
6.42886e-06
|
|
|
alsin
|
[NCBI]
|
6.42886e-06
|
|
|
IKBKAP
|
[NCBI]
|
6.42886e-06
|
|
|
MTP
|
[NCBI]
|
6.42886e-06
|
|
|
HLCS
|
[NCBI]
|
6.42886e-06
|
|
|
MCF2
|
[NCBI]
|
6.42886e-06
|
|
|
CYP3A5
|
[NCBI]
|
6.42886e-06
|
|
|
NOV
|
[NCBI]
|
6.42886e-06
|
|
|
ZP3
|
[NCBI]
|
6.42886e-06
|
|
|
CRMO
|
[NCBI]
|
6.40447e-06
|
|
|
CMM2
|
[NCBI]
|
6.40447e-06
|
|
|
SCDO1
|
[NCBI]
|
6.40447e-06
|
|
|
HOKPP
|
[NCBI]
|
6.40447e-06
|
|
|
glycogen storage disease v
|
[NCBI]
|
6.40447e-06
|
|
|
osteoporosis
|
[NCBI]
|
6.40447e-06
|
|
|
FMF
|
[NCBI]
|
6.20425e-06
|
|
|
MC1R
|
[NCBI]
|
6.12167e-06
|
|
|
FUT1
|
[NCBI]
|
6.06711e-06
|
|
|
TNNI3
|
[NCBI]
|
6.06711e-06
|
|
|
FSHB
|
[NCBI]
|
6.06711e-06
|
|
|
PFKL
|
[NCBI]
|
6.06711e-06
|
|
|
BCKDHA
|
[NCBI]
|
6.06711e-06
|
|
|
OGG1
|
[NCBI]
|
6.06711e-06
|
|
|
PRH1
|
[NCBI]
|
6.06711e-06
|
|
|
AHCY
|
[NCBI]
|
6.06711e-06
|
|
|
SORBS1
|
[NCBI]
|
6.06711e-06
|
|
|
AGTR2
|
[NCBI]
|
6.06711e-06
|
|
|
P2RX7
|
[NCBI]
|
6.06711e-06
|
|
|
GALR1
|
[NCBI]
|
6.06711e-06
|
|
|
CRYGD
|
[NCBI]
|
6.06711e-06
|
|
|
YY1
|
[NCBI]
|
6.06711e-06
|
|
|
CD1D
|
[NCBI]
|
6.06711e-06
|
|
|
AGXT
|
[NCBI]
|
6.06711e-06
|
|
|
OTC
|
[NCBI]
|
6.01991e-06
|
|
|
INSL3
|
[NCBI]
|
6.01991e-06
|
|
|
thiourea tasting
|
[NCBI]
|
5.90851e-06
|
|
|
MELAS
|
[NCBI]
|
5.90851e-06
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
5.90851e-06
|
|
|
gaucher disease, type iii
|
[NCBI]
|
5.90851e-06
|
|
|
PDB
|
[NCBI]
|
5.90851e-06
|
|
|
ODDD
|
[NCBI]
|
5.90851e-06
|
|
|
MHA
|
[NCBI]
|
5.90851e-06
|
|
|
AHC
|
[NCBI]
|
5.90851e-06
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
5.90851e-06
|
|
|
SEDC
|
[NCBI]
|
5.90851e-06
|
|
|
A2M
|
[NCBI]
|
5.87284e-06
|
|
|
LDHC
|
[NCBI]
|
5.73376e-06
|
|
|
SOCS2
|
[NCBI]
|
5.73376e-06
|
|
|
TNFRSF11A
|
[NCBI]
|
5.73376e-06
|
|
|
HPSE
|
[NCBI]
|
5.73376e-06
|
|
|
PDCD1
|
[NCBI]
|
5.73376e-06
|
|
|
UBE1
|
[NCBI]
|
5.73376e-06
|
|
|
LOR
|
[NCBI]
|
5.73376e-06
|
|
|
GGCX
|
[NCBI]
|
5.73376e-06
|
|
|
PFC
|
[NCBI]
|
5.73376e-06
|
|
|
APOA2
|
[NCBI]
|
5.73376e-06
|
|
|
ALOX5AP
|
[NCBI]
|
5.73376e-06
|
|
|
GALE
|
[NCBI]
|
5.73376e-06
|
|
|
TAP1
|
[NCBI]
|
5.73376e-06
|
|
|
SSTR5
|
[NCBI]
|
5.73376e-06
|
|
|
C4BPA
|
[NCBI]
|
5.73376e-06
|
|
|
PNMT
|
[NCBI]
|
5.70123e-06
|
|
|
TG
|
[NCBI]
|
5.66593e-06
|
|
|
PCI
|
[NCBI]
|
5.62791e-06
|
|
|
IGF2
|
[NCBI]
|
5.58956e-06
|
|
|
SLC2A2
|
[NCBI]
|
5.58956e-06
|
|
|
FBN1
|
[NCBI]
|
5.5335e-06
|
|
|
pheochromocytoma
|
[NCBI]
|
5.44597e-06
|
|
|
lung cancer
|
[NCBI]
|
5.44597e-06
|
|
|
AMY2A
|
[NCBI]
|
5.42525e-06
|
|
|
PRKCA
|
[NCBI]
|
5.42525e-06
|
|
|
ADRB1
|
[NCBI]
|
5.42525e-06
|
|
|
ZEB2
|
[NCBI]
|
5.42525e-06
|
|
|
LHX3
|
[NCBI]
|
5.42525e-06
|
|
|
CAMK2A
|
[NCBI]
|
5.42525e-06
|
|
|
THBD
|
[NCBI]
|
5.42525e-06
|
|
|
ELAC2
|
[NCBI]
|
5.42525e-06
|
|
|
LAMP2
|
[NCBI]
|
5.42525e-06
|
|
|
PCSK1
|
[NCBI]
|
5.42525e-06
|
|
|
SELE
|
[NCBI]
|
5.42525e-06
|
|
|
CYP2C9
|
[NCBI]
|
5.42525e-06
|
|
|
LYST
|
[NCBI]
|
5.42525e-06
|
|
|
HLA-DPA1
|
[NCBI]
|
5.42525e-06
|
|
|
CD99
|
[NCBI]
|
5.42525e-06
|
|
|
CYBA
|
[NCBI]
|
5.42525e-06
|
|
|
CPS1
|
[NCBI]
|
5.42525e-06
|
|
|
GABRB3
|
[NCBI]
|
5.42525e-06
|
|
|
PLIN
|
[NCBI]
|
5.42525e-06
|
|
|
PRTN3
|
[NCBI]
|
5.42525e-06
|
|
|
TPH1
|
[NCBI]
|
5.42525e-06
|
|
|
MTTS1
|
[NCBI]
|
5.42525e-06
|
|
|
CDH1
|
[NCBI]
|
5.31997e-06
|
|
|
SLOS
|
[NCBI]
|
5.22002e-06
|
|
|
HNF4A
|
[NCBI]
|
5.19002e-06
|
|
|
ADM
|
[NCBI]
|
5.14825e-06
|
|
|
KCNQ1OT1
|
[NCBI]
|
5.13865e-06
|
|
|
GABRG2
|
[NCBI]
|
5.13865e-06
|
|
|
MAN2B1
|
[NCBI]
|
5.13865e-06
|
|
|
SLC45A2
|
[NCBI]
|
5.13865e-06
|
|
|
CCR2
|
[NCBI]
|
5.13865e-06
|
|
|
CBFA2T1
|
[NCBI]
|
5.13865e-06
|
|
|
DLG4
|
[NCBI]
|
5.13865e-06
|
|
|
MIF
|
[NCBI]
|
5.13865e-06
|
|
|
ROR2
|
[NCBI]
|
5.13865e-06
|
|
|
CSH1
|
[NCBI]
|
5.13865e-06
|
|
|
GNB3
|
[NCBI]
|
5.13865e-06
|
|
|
PIP
|
[NCBI]
|
5.13865e-06
|
|
|
CALM1
|
[NCBI]
|
5.13865e-06
|
|
|
CYP11A1
|
[NCBI]
|
5.13865e-06
|
|
|
PAX1
|
[NCBI]
|
5.13865e-06
|
|
|
FGB
|
[NCBI]
|
5.13865e-06
|
|
|
PPARG
|
[NCBI]
|
5.08174e-06
|
|
|
HBFQTL1
|
[NCBI]
|
5.01428e-06
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
5.01428e-06
|
|
|
EV
|
[NCBI]
|
4.90487e-06
|
|
|
DEFA1
|
[NCBI]
|
4.87152e-06
|
|
|
IL6R
|
[NCBI]
|
4.87152e-06
|
|
|
TPM3
|
[NCBI]
|
4.87152e-06
|
|
|
GDI1
|
[NCBI]
|
4.87152e-06
|
|
|
SPG7
|
[NCBI]
|
4.87152e-06
|
|
|
TRHR
|
[NCBI]
|
4.87152e-06
|
|
|
ACTA1
|
[NCBI]
|
4.87152e-06
|
|
|
HBZ
|
[NCBI]
|
4.87152e-06
|
|
|
ACY1
|
[NCBI]
|
4.87152e-06
|
|
|
TSD
|
[NCBI]
|
4.84393e-06
|
|
|
HPRT1
|
[NCBI]
|
4.82612e-06
|
|
|
CFH
|
[NCBI]
|
4.82612e-06
|
|
|
SMS
|
[NCBI]
|
4.74754e-06
|
|
|
BCL2
|
[NCBI]
|
4.70027e-06
|
|
|
ENO1
|
[NCBI]
|
4.62182e-06
|
|
|
LRP2
|
[NCBI]
|
4.62182e-06
|
|
|
FOXL2
|
[NCBI]
|
4.62182e-06
|
|
|
CEBPB
|
[NCBI]
|
4.62182e-06
|
|
|
PCCB
|
[NCBI]
|
4.62182e-06
|
|
|
PRKCG
|
[NCBI]
|
4.62182e-06
|
|
|
usher syndrome, type i
|
[NCBI]
|
4.61116e-06
|
|
|
neural tube defects
|
[NCBI]
|
4.61116e-06
|
|
|
HSAS
|
[NCBI]
|
4.61116e-06
|
|
|
PPSH
|
[NCBI]
|
4.61116e-06
|
|
|
POF1
|
[NCBI]
|
4.61116e-06
|
|
|
DAR
|
[NCBI]
|
4.61116e-06
|
|
|
GCCR
|
[NCBI]
|
4.47214e-06
|
|
|
SCA2
|
[NCBI]
|
4.41801e-06
|
|
|
ACPP
|
[NCBI]
|
4.40484e-06
|
|
|
tay-sachs disease, ab variant
|
[NCBI]
|
4.38779e-06
|
|
|
SYT1
|
[NCBI]
|
4.38779e-06
|
|
|
FTH1
|
[NCBI]
|
4.38779e-06
|
|
|
AMELX
|
[NCBI]
|
4.38779e-06
|
|
|
CACNA1S
|
[NCBI]
|
4.38779e-06
|
|
|
PHB
|
[NCBI]
|
4.38779e-06
|
|
|
EPB41
|
[NCBI]
|
4.38779e-06
|
|
|
ERCC6
|
[NCBI]
|
4.38779e-06
|
|
|
GAD2
|
[NCBI]
|
4.38779e-06
|
|
|
LCP1
|
[NCBI]
|
4.38779e-06
|
|
|
BMP1
|
[NCBI]
|
4.38779e-06
|
|
|
NCSTN
|
[NCBI]
|
4.38779e-06
|
|
|
DBT
|
[NCBI]
|
4.38779e-06
|
|
|
ESD
|
[NCBI]
|
4.34704e-06
|
|
|
CVID
|
[NCBI]
|
4.27199e-06
|
|
|
CYP1A1
|
[NCBI]
|
4.23457e-06
|
|
|
STGD1
|
[NCBI]
|
4.23456e-06
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
4.23456e-06
|
|
|
ORM1
|
[NCBI]
|
4.16795e-06
|
|
|
SSTR2
|
[NCBI]
|
4.16795e-06
|
|
|
ALPP
|
[NCBI]
|
4.16795e-06
|
|
|
MAP4
|
[NCBI]
|
4.16795e-06
|
|
|
FLT1
|
[NCBI]
|
4.16795e-06
|
|
|
RXRA
|
[NCBI]
|
4.16795e-06
|
|
|
ANXA1
|
[NCBI]
|
4.16795e-06
|
|
|
TDG
|
[NCBI]
|
4.16795e-06
|
|
|
NME1
|
[NCBI]
|
4.16795e-06
|
|
|
HLA-G
|
[NCBI]
|
4.16795e-06
|
|
|
ANG
|
[NCBI]
|
4.14907e-06
|
|
|
ADA
|
[NCBI]
|
4.14651e-06
|
|
|
KRT1
|
[NCBI]
|
3.961e-06
|
|
|
PAX5
|
[NCBI]
|
3.961e-06
|
|
|
GHSR
|
[NCBI]
|
3.961e-06
|
|
|
IL1RN
|
[NCBI]
|
3.961e-06
|
|
|
PLOD1
|
[NCBI]
|
3.961e-06
|
|
|
HLA-DQB1
|
[NCBI]
|
3.961e-06
|
|
|
complement component 8 deficiency, type i
|
[NCBI]
|
3.961e-06
|
|
|
JUN
|
[NCBI]
|
3.961e-06
|
|
|
F12
|
[NCBI]
|
3.961e-06
|
|
|
DKC1
|
[NCBI]
|
3.961e-06
|
|
|
CYP27B1
|
[NCBI]
|
3.961e-06
|
|
|
ATP2A2
|
[NCBI]
|
3.961e-06
|
|
|
OR1D2
|
[NCBI]
|
3.961e-06
|
|
|
EBP
|
[NCBI]
|
3.961e-06
|
|
|
RET
|
[NCBI]
|
3.90754e-06
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
3.88266e-06
|
|
|
graves disease
|
[NCBI]
|
3.88266e-06
|
|
|
NR0B2
|
[NCBI]
|
3.84728e-06
|
|
|
LOX
|
[NCBI]
|
3.84728e-06
|
|
|
VAMP2
|
[NCBI]
|
3.76581e-06
|
|
|
PLAT
|
[NCBI]
|
3.76581e-06
|
|
|
AACT
|
[NCBI]
|
3.76581e-06
|
|
|
PAX8
|
[NCBI]
|
3.76581e-06
|
|
|
NR3C2
|
[NCBI]
|
3.76581e-06
|
|
|
GJB3
|
[NCBI]
|
3.76581e-06
|
|
|
CYP1B1
|
[NCBI]
|
3.76581e-06
|
|
|
ANXA5
|
[NCBI]
|
3.76581e-06
|
|
|
CAPN10
|
[NCBI]
|
3.76581e-06
|
|
|
DLD
|
[NCBI]
|
3.76581e-06
|
|
|
CASP8
|
[NCBI]
|
3.76581e-06
|
|
|
LTC4S
|
[NCBI]
|
3.76581e-06
|
|
|
IAPP
|
[NCBI]
|
3.66196e-06
|
|
|
FGA
|
[NCBI]
|
3.65706e-06
|
|
|
DDC
|
[NCBI]
|
3.63479e-06
|
|
|
EMD
|
[NCBI]
|
3.58142e-06
|
|
|
IL12A
|
[NCBI]
|
3.58142e-06
|
|
|
PMM2
|
[NCBI]
|
3.58142e-06
|
|
|
EDA
|
[NCBI]
|
3.58142e-06
|
|
|
CRYAA
|
[NCBI]
|
3.58142e-06
|
|
|
DDIT3
|
[NCBI]
|
3.58142e-06
|
|
|
MTND3
|
[NCBI]
|
3.58142e-06
|
|
|
OSBP
|
[NCBI]
|
3.58142e-06
|
|
|
BRCA1
|
[NCBI]
|
3.57477e-06
|
|
|
BCPM
|
[NCBI]
|
3.5538e-06
|
|
|
LGMD2C
|
[NCBI]
|
3.5538e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
3.52874e-06
|
|
|
CRP
|
[NCBI]
|
3.40695e-06
|
|
|
SRD5A2
|
[NCBI]
|
3.40695e-06
|
|
|
MTCO3
|
[NCBI]
|
3.40695e-06
|
|
|
EGR2
|
[NCBI]
|
3.40695e-06
|
|
|
SLC12A3
|
[NCBI]
|
3.40695e-06
|
|
|
MYH9
|
[NCBI]
|
3.40695e-06
|
|
|
DGS
|
[NCBI]
|
3.33347e-06
|
|
|
GTS
|
[NCBI]
|
3.25816e-06
|
|
|
SGBS1
|
[NCBI]
|
3.2465e-06
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
3.2465e-06
|
|
|
GLO1
|
[NCBI]
|
3.24164e-06
|
|
|
GALC
|
[NCBI]
|
3.24164e-06
|
|
|
ETS1
|
[NCBI]
|
3.24164e-06
|
|
|
PGP
|
[NCBI]
|
3.24164e-06
|
|
|
BMP15
|
[NCBI]
|
3.24164e-06
|
|
|
SLN
|
[NCBI]
|
3.24164e-06
|
|
|
NRAS
|
[NCBI]
|
3.24164e-06
|
|
|
pta deficiency
|
[NCBI]
|
3.24164e-06
|
|
|
amyloidosis vi
|
[NCBI]
|
3.21403e-06
|
|
|
MTR
|
[NCBI]
|
3.13422e-06
|
|
|
AHSG
|
[NCBI]
|
3.08481e-06
|
|
|
CRYAB
|
[NCBI]
|
3.08481e-06
|
|
|
CTSK
|
[NCBI]
|
3.08481e-06
|
|
|
OPA1
|
[NCBI]
|
3.08481e-06
|
|
|
CREB1
|
[NCBI]
|
3.08481e-06
|
|
|
MLP
|
[NCBI]
|
3.08481e-06
|
|
|
MVK
|
[NCBI]
|
3.08481e-06
|
|
|
ILK
|
[NCBI]
|
3.08402e-06
|
|
|
BSG
|
[NCBI]
|
3.05355e-06
|
|
|
FMR1
|
[NCBI]
|
3.04708e-06
|
|
|
PKS
|
[NCBI]
|
2.95941e-06
|
|
|
PGL1
|
[NCBI]
|
2.95941e-06
|
|
|
AICDA
|
[NCBI]
|
2.93586e-06
|
|
|
CHRNE
|
[NCBI]
|
2.93586e-06
|
|
|
CD8A
|
[NCBI]
|
2.93586e-06
|
|
|
INPP5D
|
[NCBI]
|
2.93586e-06
|
|
|
GAS
|
[NCBI]
|
2.93586e-06
|
|
|
DYT1
|
[NCBI]
|
2.93586e-06
|
|
|
contractural arachnodactyly, congenital
|
[NCBI]
|
2.93586e-06
|
|
|
PROP1
|
[NCBI]
|
2.93586e-06
|
|
|
TNFRSF10A
|
[NCBI]
|
2.79424e-06
|
|
|
CALCA
|
[NCBI]
|
2.79424e-06
|
|
|
SPTB
|
[NCBI]
|
2.79424e-06
|
|
|
TCRB
|
[NCBI]
|
2.79424e-06
|
|
|
FABP2
|
[NCBI]
|
2.79424e-06
|
|
|
PRSS1
|
[NCBI]
|
2.79424e-06
|
|
|
TAF1
|
[NCBI]
|
2.79424e-06
|
|
|
TFF1
|
[NCBI]
|
2.79424e-06
|
|
|
IGF2R
|
[NCBI]
|
2.79424e-06
|
|
|
KRT14
|
[NCBI]
|
2.79424e-06
|
|
|
THRA
|
[NCBI]
|
2.79424e-06
|
|
|
SLC3A2
|
[NCBI]
|
2.79424e-06
|
|
|
PLN
|
[NCBI]
|
2.74772e-06
|
|
|
CML
|
[NCBI]
|
2.6913e-06
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
2.6913e-06
|
|
|
SPG4
|
[NCBI]
|
2.6913e-06
|
|
|
wilson disease
|
[NCBI]
|
2.68678e-06
|
|
|
COMP
|
[NCBI]
|
2.68446e-06
|
|
|
TTN
|
[NCBI]
|
2.65946e-06
|
|
|
CHGA
|
[NCBI]
|
2.65946e-06
|
|
|
DISC1
|
[NCBI]
|
2.65946e-06
|
|
|
PROS1
|
[NCBI]
|
2.65946e-06
|
|
|
NOS2A
|
[NCBI]
|
2.65946e-06
|
|
|
krabbe disease
|
[NCBI]
|
2.60774e-06
|
|
|
UCP3
|
[NCBI]
|
2.60439e-06
|
|
|
APOH
|
[NCBI]
|
2.53108e-06
|
|
|
CD40LG
|
[NCBI]
|
2.53108e-06
|
|
|
CYP11B2
|
[NCBI]
|
2.53108e-06
|
|
|
TWIST1
|
[NCBI]
|
2.53108e-06
|
|
|
ALK
|
[NCBI]
|
2.50802e-06
|
|
|
CLL
|
[NCBI]
|
2.44107e-06
|
|
|
PCTT
|
[NCBI]
|
2.44107e-06
|
|
|
IL6
|
[NCBI]
|
2.43254e-06
|
|
|
ERCC2
|
[NCBI]
|
2.4087e-06
|
|
|
IGF1R
|
[NCBI]
|
2.4087e-06
|
|
|
AK1
|
[NCBI]
|
2.4087e-06
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
2.4087e-06
|
|
|
MET
|
[NCBI]
|
2.4087e-06
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
2.4087e-06
|
|
|
MEFV
|
[NCBI]
|
2.4087e-06
|
|
|
DCN
|
[NCBI]
|
2.4087e-06
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
2.40059e-06
|
|
|
CD
|
[NCBI]
|
2.35753e-06
|
|
|
PLG
|
[NCBI]
|
2.33718e-06
|
|
|
SMN1
|
[NCBI]
|
2.33551e-06
|
|
|
ENPP1
|
[NCBI]
|
2.29196e-06
|
|
|
IL12B
|
[NCBI]
|
2.29196e-06
|
|
|
CXCL12
|
[NCBI]
|
2.29196e-06
|
|
|
MAOB
|
[NCBI]
|
2.29196e-06
|
|
|
TERC
|
[NCBI]
|
2.29196e-06
|
|
|
FASN
|
[NCBI]
|
2.29196e-06
|
|
|
IL8
|
[NCBI]
|
2.29196e-06
|
|
|
MTND5
|
[NCBI]
|
2.29196e-06
|
|
|
LRP1
|
[NCBI]
|
2.28247e-06
|
|
|
TF
|
[NCBI]
|
2.27575e-06
|
|
|
GRP
|
[NCBI]
|
2.26687e-06
|
|
|
EPOR
|
[NCBI]
|
2.26687e-06
|
|
|
FIH
|
[NCBI]
|
2.20768e-06
|
|
|
CLCN1
|
[NCBI]
|
2.18053e-06
|
|
|
CYBB
|
[NCBI]
|
2.18053e-06
|
|
|
CFI
|
[NCBI]
|
2.18053e-06
|
|
|
PAFAH1B1
|
[NCBI]
|
2.18053e-06
|
|
|
POU1F1
|
[NCBI]
|
2.18053e-06
|
|
|
HP
|
[NCBI]
|
2.12658e-06
|
|
|
GLB1
|
[NCBI]
|
2.07409e-06
|
|
|
PPOX
|
[NCBI]
|
2.07409e-06
|
|
|
ERCC5
|
[NCBI]
|
2.07409e-06
|
|
|
MTTK
|
[NCBI]
|
2.07409e-06
|
|
|
SPG4
|
[NCBI]
|
2.07409e-06
|
|
|
LFS1
|
[NCBI]
|
1.99021e-06
|
|
|
COH1
|
[NCBI]
|
1.99021e-06
|
|
|
lactase persistence
|
[NCBI]
|
1.99021e-06
|
|
|
PSEN1
|
[NCBI]
|
1.9761e-06
|
|
|
GDF5
|
[NCBI]
|
1.97238e-06
|
|
|
CYP2A6
|
[NCBI]
|
1.97238e-06
|
|
|
TNFSF13B
|
[NCBI]
|
1.97238e-06
|
|
|
EPHX1
|
[NCBI]
|
1.97238e-06
|
|
|
ICAM1
|
[NCBI]
|
1.97238e-06
|
|
|
TYRP1
|
[NCBI]
|
1.97238e-06
|
|
|
GHRL
|
[NCBI]
|
1.97238e-06
|
|
|
IGKC
|
[NCBI]
|
1.97238e-06
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
1.97238e-06
|
|
|
APS1
|
[NCBI]
|
1.8857e-06
|
|
|
PAI1
|
[NCBI]
|
1.87514e-06
|
|
|
AIRE
|
[NCBI]
|
1.86209e-06
|
|
|
KITLG
|
[NCBI]
|
1.81158e-06
|
|
|
PRLR
|
[NCBI]
|
1.80842e-06
|
|
|
GH1
|
[NCBI]
|
1.80842e-06
|
|
|
IL4
|
[NCBI]
|
1.80842e-06
|
|
|
GLC1A
|
[NCBI]
|
1.78778e-06
|
|
|
ASPA
|
[NCBI]
|
1.78213e-06
|
|
|
ADRP
|
[NCBI]
|
1.78213e-06
|
|
|
MTCO1
|
[NCBI]
|
1.78213e-06
|
|
|
GK
|
[NCBI]
|
1.78213e-06
|
|
|
CFTR
|
[NCBI]
|
1.7465e-06
|
|
|
FANCC
|
[NCBI]
|
1.69314e-06
|
|
|
PTPRC
|
[NCBI]
|
1.69314e-06
|
|
|
TPI1
|
[NCBI]
|
1.69314e-06
|
|
|
OPTN
|
[NCBI]
|
1.69314e-06
|
|
|
VIM
|
[NCBI]
|
1.65419e-06
|
|
|
RHCE
|
[NCBI]
|
1.60796e-06
|
|
|
NOD2
|
[NCBI]
|
1.60796e-06
|
|
|
C4B
|
[NCBI]
|
1.60796e-06
|
|
|
EDNRB
|
[NCBI]
|
1.60796e-06
|
|
|
HHF1
|
[NCBI]
|
1.59962e-06
|
|
|
GUSB
|
[NCBI]
|
1.5568e-06
|
|
|
CUTL1
|
[NCBI]
|
1.52642e-06
|
|
|
EDN1
|
[NCBI]
|
1.52642e-06
|
|
|
PDHA1
|
[NCBI]
|
1.44832e-06
|
|
|
MST1
|
[NCBI]
|
1.44832e-06
|
|
|
CSF2
|
[NCBI]
|
1.44832e-06
|
|
|
SMEI
|
[NCBI]
|
1.42498e-06
|
|
|
MMP3
|
[NCBI]
|
1.37353e-06
|
|
|
GLA
|
[NCBI]
|
1.30188e-06
|
|
|
LPA
|
[NCBI]
|
1.30188e-06
|
|
|
ENG
|
[NCBI]
|
1.23323e-06
|
|
|
GJB2
|
[NCBI]
|
1.18413e-06
|
|
|
AIS
|
[NCBI]
|
1.17143e-06
|
|
|
DAZ
|
[NCBI]
|
1.16746e-06
|
|
|
KAL1
|
[NCBI]
|
1.16746e-06
|
|
|
RUNX1
|
[NCBI]
|
1.16746e-06
|
|
|
GSR
|
[NCBI]
|
1.16746e-06
|
|
|
TCRA
|
[NCBI]
|
1.16746e-06
|
|
|
OXT
|
[NCBI]
|
1.12485e-06
|
|
|
MCP
|
[NCBI]
|
1.09984e-06
|
|
|
TERT
|
[NCBI]
|
1.07296e-06
|
|
|
GHR
|
[NCBI]
|
1.04674e-06
|
|
|
factor x deficiency
|
[NCBI]
|
1.04407e-06
|
|
|
DCT
|
[NCBI]
|
1.04407e-06
|
|
|
TCF7L2
|
[NCBI]
|
1.04407e-06
|
|
|
AMH
|
[NCBI]
|
1.02822e-06
|
|
|
SOD1
|
[NCBI]
|
1.00079e-06
|
|
|
COL7A1
|
[NCBI]
|
9.86219e-07
|
|
|
RTS
|
[NCBI]
|
9.7572e-07
|
|
|
AANAT
|
[NCBI]
|
9.30799e-07
|
|
|
FGF23
|
[NCBI]
|
9.30799e-07
|
|
|
UCP2
|
[NCBI]
|
9.15696e-07
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
8.94558e-07
|
|
|
CACNA1A
|
[NCBI]
|
8.77713e-07
|
|
|
NGFR
|
[NCBI]
|
8.66377e-07
|
|
|
LAD
|
[NCBI]
|
8.48904e-07
|
|
|
ABL
|
[NCBI]
|
8.48904e-07
|
|
|
EDMD
|
[NCBI]
|
8.48904e-07
|
|
|
MECP2
|
[NCBI]
|
8.41658e-07
|
|
|
ABCB1
|
[NCBI]
|
8.41658e-07
|
|
|
SH2D1A
|
[NCBI]
|
8.26871e-07
|
|
|
HS
|
[NCBI]
|
8.26871e-07
|
|
|
PVR
|
[NCBI]
|
8.26871e-07
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
8.12105e-07
|
|
|
PSAP
|
[NCBI]
|
7.78189e-07
|
|
|
NS1
|
[NCBI]
|
7.32993e-07
|
|
|
ALGS1
|
[NCBI]
|
7.32684e-07
|
|
|
GALT
|
[NCBI]
|
7.31586e-07
|
|
|
AGT
|
[NCBI]
|
7.31586e-07
|
|
|
B2M
|
[NCBI]
|
7.31586e-07
|
|
|
FXN
|
[NCBI]
|
7.31586e-07
|
|
|
MITF
|
[NCBI]
|
7.30397e-07
|
|
|
LHCGR
|
[NCBI]
|
6.86987e-07
|
|
|
ITGB2
|
[NCBI]
|
6.86987e-07
|
|
|
PSORS1
|
[NCBI]
|
6.5731e-07
|
|
|
SLC18A2
|
[NCBI]
|
6.4432e-07
|
|
|
TBP
|
[NCBI]
|
6.31139e-07
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
6.26591e-07
|
|
|
SCA6
|
[NCBI]
|
6.26591e-07
|
|
|
PRNP
|
[NCBI]
|
6.11711e-07
|
|
|
LBR
|
[NCBI]
|
6.03517e-07
|
|
|
C3
|
[NCBI]
|
6.03517e-07
|
|
|
AHO
|
[NCBI]
|
5.85146e-07
|
|
|
PSEN2
|
[NCBI]
|
5.64514e-07
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
5.30183e-07
|
|
|
RPGR
|
[NCBI]
|
5.27251e-07
|
|
|
CEL
|
[NCBI]
|
5.27251e-07
|
|
|
ALD
|
[NCBI]
|
5.2468e-07
|
|
|
OMP
|
[NCBI]
|
5.24132e-07
|
|
|
CCD
|
[NCBI]
|
5.16598e-07
|
|
|
ACE
|
[NCBI]
|
5.08083e-07
|
|
|
SDC2
|
[NCBI]
|
4.89194e-07
|
|
|
PGK1
|
[NCBI]
|
4.57712e-07
|
|
|
IGF1
|
[NCBI]
|
4.57712e-07
|
|
|
ASL
|
[NCBI]
|
4.57712e-07
|
|
|
KDR
|
[NCBI]
|
4.56013e-07
|
|
|
breast cancer
|
[NCBI]
|
4.51763e-07
|
|
|
galactosemia
|
[NCBI]
|
4.43048e-07
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
4.43048e-07
|
|
|
WT1
|
[NCBI]
|
4.2533e-07
|
|
|
HRAS
|
[NCBI]
|
4.2533e-07
|
|
|
RHO
|
[NCBI]
|
4.14382e-07
|
|
|
NF2
|
[NCBI]
|
3.9447e-07
|
|
|
DHFR
|
[NCBI]
|
3.71383e-07
|
|
|
CYP19A1
|
[NCBI]
|
3.65087e-07
|
|
|
HHT
|
[NCBI]
|
3.64801e-07
|
|
|
TLR4
|
[NCBI]
|
3.61525e-07
|
|
|
ALB
|
[NCBI]
|
3.43775e-07
|
|
|
EIF4E
|
[NCBI]
|
3.10569e-07
|
|
|
BIRC1
|
[NCBI]
|
3.10569e-07
|
|
|
SPARC
|
[NCBI]
|
3.10569e-07
|
|
|
MAPT
|
[NCBI]
|
3.0014e-07
|
|
|
maple syrup urine disease
|
[NCBI]
|
2.95078e-07
|
|
|
AN2
|
[NCBI]
|
2.95078e-07
|
|
|
EIG
|
[NCBI]
|
2.93936e-07
|
|
|
SOD2
|
[NCBI]
|
2.92035e-07
|
|
|
AGER
|
[NCBI]
|
2.86849e-07
|
|
|
BGLAP
|
[NCBI]
|
2.86849e-07
|
|
|
TGFB1
|
[NCBI]
|
2.8535e-07
|
|
|
IBD1
|
[NCBI]
|
2.80595e-07
|
|
|
GC
|
[NCBI]
|
2.70835e-07
|
|
|
GPT
|
[NCBI]
|
2.61437e-07
|
|
|
CDC2
|
[NCBI]
|
2.61437e-07
|
|
|
GJB1
|
[NCBI]
|
2.52145e-07
|
|
|
WBS
|
[NCBI]
|
2.50991e-07
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
2.38792e-07
|
|
|
CTNNB1
|
[NCBI]
|
2.38792e-07
|
|
|
NPM1
|
[NCBI]
|
2.36919e-07
|
|
|
TYMS
|
[NCBI]
|
2.34531e-07
|
|
|
CLS
|
[NCBI]
|
2.3354e-07
|
|
|
APOD
|
[NCBI]
|
2.17379e-07
|
|
|
THPO
|
[NCBI]
|
2.17379e-07
|
|
|
STAR
|
[NCBI]
|
2.14938e-07
|
|
|
BMP4
|
[NCBI]
|
2.07664e-07
|
|
|
MAPK3
|
[NCBI]
|
1.97164e-07
|
|
|
JAK2
|
[NCBI]
|
1.94377e-07
|
|
|
asthma, susceptibility to
|
[NCBI]
|
1.87062e-07
|
|
|
AVSD
|
[NCBI]
|
1.87062e-07
|
|
|
ALS1
|
[NCBI]
|
1.87062e-07
|
|
|
CP
|
[NCBI]
|
1.80554e-07
|
|
|
ABCC8
|
[NCBI]
|
1.80049e-07
|
|
|
IL10
|
[NCBI]
|
1.78113e-07
|
|
|
CPI
|
[NCBI]
|
1.62094e-07
|
|
|
DRD4
|
[NCBI]
|
1.60194e-07
|
|
|
PENK
|
[NCBI]
|
1.60194e-07
|
|
|
menkes disease
|
[NCBI]
|
1.46836e-07
|
|
|
RBP1
|
[NCBI]
|
1.41825e-07
|
|
|
SLC2A4
|
[NCBI]
|
1.38687e-07
|
|
|
HSCR1
|
[NCBI]
|
1.32961e-07
|
|
|
LRRK2
|
[NCBI]
|
1.27632e-07
|
|
|
SLC4A1
|
[NCBI]
|
1.27632e-07
|
|
|
LCAT
|
[NCBI]
|
1.2653e-07
|
|
|
PAX6
|
[NCBI]
|
1.12931e-07
|
|
|
PC
|
[NCBI]
|
1.07618e-07
|
|
|
BCHE
|
[NCBI]
|
1.00387e-07
|
|
|
MLH1
|
[NCBI]
|
9.92475e-08
|
|
|
PARK2
|
[NCBI]
|
9.92475e-08
|
|
|
NRG1
|
[NCBI]
|
9.7146e-08
|
|
|
VWS
|
[NCBI]
|
9.49099e-08
|
|
|
hurler syndrome
|
[NCBI]
|
9.49099e-08
|
|
|
PARP1
|
[NCBI]
|
8.65548e-08
|
|
|
FGFR2
|
[NCBI]
|
8.21277e-08
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
8.01311e-08
|
|
|
SI
|
[NCBI]
|
7.76465e-08
|
|
|
MYOC
|
[NCBI]
|
7.76465e-08
|
|
|
BMP2
|
[NCBI]
|
7.48279e-08
|
|
|
CD
|
[NCBI]
|
7.05024e-08
|
|
|
TSHR
|
[NCBI]
|
6.40427e-08
|
|
|
NPC1
|
[NCBI]
|
6.30768e-08
|
|
|
SNCA
|
[NCBI]
|
5.41759e-08
|
|
|
LPI
|
[NCBI]
|
5.39376e-08
|
|
|
SERPINA6
|
[NCBI]
|
4.85619e-08
|
|
|
SCD
|
[NCBI]
|
3.77517e-08
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
3.27184e-08
|
|
|
MYC
|
[NCBI]
|
2.34574e-08
|
|
|
SST
|
[NCBI]
|
2.30082e-08
|
|
|
BCNS
|
[NCBI]
|
2.11563e-08
|
|
|
PTGS2
|
[NCBI]
|
2.02779e-08
|
|
|
CLU
|
[NCBI]
|
1.78626e-08
|
|
|
TPO
|
[NCBI]
|
1.77322e-08
|
|
|
porphyria variegata
|
[NCBI]
|
1.66338e-08
|
|
|
CHH
|
[NCBI]
|
1.66338e-08
|
|
|
SVAS
|
[NCBI]
|
1.66338e-08
|
|
|
TD1
|
[NCBI]
|
1.66338e-08
|
|
|
gaucher disease, type i
|
[NCBI]
|
1.66338e-08
|
|
|
LCT
|
[NCBI]
|
9.04133e-09
|
|
|
CPE
|
[NCBI]
|
8.00618e-09
|
|
|
KSS
|
[NCBI]
|
6.5629e-09
|
|
|
NIDDM
|
[NCBI]
|
5.85198e-09
|
|
|
OPRM1
|
[NCBI]
|
5.12641e-09
|
|
|
HEXA
|
[NCBI]
|
3.86951e-10
|
|
|
LBP
|
[NCBI]
|
3.86951e-10
|
|
|
TNFRSF1A
|
[NCBI]
|
3.86951e-10
|
|
|
HNF1A
|
[NCBI]
|
2.96591e-10
|
|